RESULT_COUNT: 375,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Report Third Quarter 2017 Financial Results Before The Market Opens On Wednesday, October 25, 2017",2017-10-19 10:00:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-report-third-100000254.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Oct. 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2017 financial results ..."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-10-17 12:06:14 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120614017.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-10-16 13:46:10 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-134610919.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,Why These Biotech Players Look Poised To Crush Earnings Views,2017-10-13 22:16:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uYjC4ojl3iY/why-these-biotech-players-look-poised-to-crush-earnings-views-cm859687,Biogen BIIB Gilead Sciences GILD and Sarepta Therapeutics SRPT will build on momentum in the biotech sphere to beat Wall Street expectations for the third quarter an analyst predicted Friday ibd display video id 2359800 width 50 float
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-10-13 12:06:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120630136.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 11.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics’s Net Profit Margins Are Expected to Narrow,2017-10-09 14:39:45 +0000,http://finance.yahoo.com/r/6e07fff1-3086-3128-9af7-5a2db14379ae/united-therapeutics-expected-witness-significant-decline-net-profit-margins-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In December 2014, United Therapeutics (UTHR) collaborated with DEKA Research & Development to develop a pre-filled and semi-disposable pump, RemUnity, for the continuous and subcutaneous administration ..."
UTHR,UTHR:UW,BBG000BV5663,Why United Therapeutics’ Revenue May Rise in 2017,2017-10-09 13:13:28 +0000,http://finance.yahoo.com/r/b0ec11e9-200c-31b3-98c9-753e39ff7904/united-therapeutics-may-witness-small-rise-revenues-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"United Therapeutics (UTHR) has completed patient enrolment in its Phase 3 trial BEAT, which aims to evaluate the efficacy and safety of a combination regimen of oral esuberapros plus inhaled Tyvaso in ..."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-10-09 12:06:51 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120651012.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 11.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,Analysts’ Recommendations for United Therapeutics,2017-10-09 11:44:06 +0000,http://finance.yahoo.com/r/f2f322a2-1fe6-33a7-9711-59c20af78443/analysts-recommendations-united-therapeutics-peers-october-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, United Therapeutics (UTHR) reported revenue of ~$445 million, representing year-over-year growth of around 8%."
UTHR,UTHR:UW,BBG000BV5663,Is United Therapeutics a Great Stock for Value Investors?,2017-09-21 15:40:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/m5aMGqdpqzE/is-united-therapeutics-a-great-stock-for-value-investors-cm848998,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
UTHR,UTHR:UW,BBG000BV5663,Implied BBH Analyst Target Price: $150,2017-09-21 15:39:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Rp9AQQjccAw/implied-bbh-analyst-target-price-150-cm849034,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
UTHR,UTHR:UW,BBG000BV5663,Is United Therapeutics a Great Stock for Value Investors?,2017-09-21 13:35:01 +0000,https://finance.yahoo.com/news/united-therapeutics-great-stock-value-133501379.html?.tsrc=rss,Let&apos;s see if United Therapeutics Corporation (UTHR) stock is a good choice for value-oriented investors right now from multiple angles.
UTHR,UTHR:UW,BBG000BV5663,Martine Rothblatt is Featured in Forbes Magazine's Special Centennial Issue as one of The World's 100 Greatest Living Business Minds,2017-09-19 13:00:00 +0000,https://finance.yahoo.com/news/martine-rothblatt-featured-forbes-magazines-130000827.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 19, 2017 /PRNewswire/ -- Martine Rothblatt, Chairman and Chief Executive Officer of United Therapeutics Corporation (UTHR) is featured in Forbes magazine's special centennial issue, released today, as one of The World's 100 Greatest Living Business Minds.  ""I'm very honored to help recognize Forbes magazine's centennial,"" said Dr. Rothblatt.  As United Therapeutics moves forward with manufacturing an unlimited supply of transplantable organs, we feel the makings of a new paradigm of abundance from that magical trifecta of engineering, entrepreneurialism and enthusiasm for creating a better life for all."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-09-18 12:06:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120623732.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 11.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-09-15 12:03:44 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120344278.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 11.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-09-13 12:02:40 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120240850.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 11.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-09-12 12:02:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120405248.html?.tsrc=rss,"This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on September 8.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : September 11, 2017",2017-09-11 14:43:19 +0000,http://finance.yahoo.com/r/d53fe1ce-c713-3cde-8821-f87410d86e47/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-uthr-us-september-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-09-11 12:02:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120242743.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on September 6.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,"Health Care Sector Update for 09/08/2017: UTHR,KURA,TNDM",2017-09-08 20:29:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XRJJC_T94Kg/health-care-sector-update-for-09082017-uthrkuratndm-cm843168,Top Health Care StocksTop Health Care Stocks JNJ 0 88 JNJ 0 88 PFE 0 44 PFE 0 44 ABT 1 10 ABT 1 10 MRK 0 03 MRK 0 03 AMGN 0 03 AMGN 0 03 Health care stocks benefitted from Friday s largely defensive trade with the NYSE Health Care Index adding more than 0 5 in value today
UTHR,UTHR:UW,BBG000BV5663,Here's Why United Therapeutics Sank as Much as 10.8% Today,2017-09-08 18:51:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7Gxpc7x5oQ4/heres-why-united-therapeutics-sank-as-much-as-108-today-cm843091,What happened Shares of rare disease specialist United Therapeutics NASDAQ UTHR dropped nearly 11 today after the company announced that a phase 3 trial evaluating Orenitram in patients with pulmonary arterial hypertension or PAH will continue through completion after
UTHR,UTHR:UW,BBG000BV5663,Here&apos;s Why United Therapeutics Sank as Much as 10.8% Today,2017-09-08 17:23:00 +0000,http://finance.yahoo.com/r/2d4954c3-7971-3929-8549-d030d30caca0/heres-why-united-therapeutics-sank-as-much-as-108.aspx?yptr=yahoo&.tsrc=rss,"The niche biopharma announced that a trial will run through completion, but investors were hoping for better."
UTHR,UTHR:UW,BBG000BV5663,"Christmas Comes Early For KURA, ANTH On Track, ABBV Hits All-time High",2017-09-08 02:46:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f0NOOpQeAZw/christmas-comes-early-for-kura-anth-on-track-abbv-hits-alltime-high-20170908-00063,"Christmas Comes Early For KURA, ANTH On Track, ABBV Hits All-time High"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces FREEDOM-EV Study Of Orenitram® To Continue As Planned Following Interim Analysis,2017-09-08 00:00:00 +0000,https://finance.yahoo.com/news/united-therapeutics-announces-freedom-ev-000000528.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that the independent data monitoring committee (DMC) for the FREEDOM-EV study of Orenitram (treprostinil) extended-release tablets had completed a pre-specified interim safety and efficacy analysis.  The DMC did not identify any new safety concerns associated with Orenitram therapy, and recommended that the trial be continued as planned without modification.  FREEDOM-EV is a Phase 3, international, multi-center, randomized, double-blind, placebo-controlled, clinical worsening study of Orenitram in patients with pulmonary arterial hypertension (PAH) receiving background oral monotherapy study (a phosphodiesterase type 5 inhibitor or an endothelin receptor antagonist)."
UTHR,UTHR:UW,BBG000BV5663,J&J (JNJ) PAH Drug's U.S. Label Expanded for Pediatric Use,2017-09-07 16:54:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5SdQxROtI-0/jj-jnj-pah-drugs-us-label-expanded-for-pediatric-use-cm842385,Johnson amp Johnson JNJ a healthcare bellwether announced that the FDA has approved a label expansion for its oral pulmonary arterial hypertension PAH medicine Tracleer Consequently a 32 mg tablet of Tracleer is now approved for use in pediatric patients aged three years and
UTHR,UTHR:UW,BBG000BV5663,First Week of UTHR October 20th Options Trading,2017-09-07 14:52:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TsdRTZZvAVk/first-week-of-uthr-october-20th-options-trading-cm842272,Investors in United Therapeutics Corp Symbol UTHR saw new options begin trading this week for the October 20th expiration At Stock Options Channel our YieldBoost formula has looked up and down the UTHR options chain for the new October 20th contracts and identified one put and one
UTHR,UTHR:UW,BBG000BV5663,First Week of UTHR February 2018 Options Trading,2017-09-06 15:52:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BhupznROsYU/first-week-of-uthr-february-2018-options-trading-cm841589,Investors in United Therapeutics Corp Symbol UTHR saw new options begin trading this week for the February 2018 expiration One of the key data points that goes into the price an option buyer is willing to pay is the time value so with 163 days until expiration the newly trading
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : September 1, 2017",2017-09-01 14:05:05 +0000,http://finance.yahoo.com/r/6c54fc6f-cfcc-388a-81f5-191936029125/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-uthr-us-september-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,How United Therapeutics’ Adcirca and Tyvaso Are Positioned in 3Q17,2017-09-01 11:37:19 +0000,http://finance.yahoo.com/r/ed68c9cb-d716-333a-8fc6-413f40acd658/how-united-therapeutics-adcirca-and-tyvaso-are-positioned-in-3q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, United Therapeutics’ (UTHR) Adcirca generated revenues of around $120.6 million."
UTHR,UTHR:UW,BBG000BV5663,Ligand Pharmaceuticals Focuses on Increasing Returns for Shareholders,2017-09-01 11:36:41 +0000,http://finance.yahoo.com/r/47c644c8-feee-30ec-84c9-4d56b6218e1a/ligand-pharmaceuticals-focused-increasing-returns-shareholders-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Ligand Pharmaceuticals has developed a product portfolio that spans more than 700 patents offering varying degrees of protection to the assets.
UTHR,UTHR:UW,BBG000BV5663,"IPXL Reveals Oriental Stakeholder, LENS Has A Vision, STDY Is Very Shaky",2017-08-31 21:55:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ROot-VXEmZc/ipxl-reveals-oriental-stakeholder-lens-has-a-vision-stdy-is-very-shaky-20170831-01377,"IPXL Reveals Oriental Stakeholder, LENS Has A Vision, STDY Is Very Shaky"
UTHR,UTHR:UW,BBG000BV5663,How United Therapeutics’ Remodulin and Tyvaso Are Performing,2017-08-31 14:37:47 +0000,http://finance.yahoo.com/r/3e6d5913-fde8-3a1d-ab80-0c69ca04777d/how-united-therapeutics-remodulin-and-tyvaso-are-performing?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, United Therapeutics’ (UTHR) Remodulin generated revenues of around $158 million, which reflected ~8% growth on a quarter-over-quarter basis."
UTHR,UTHR:UW,BBG000BV5663,Technology Platforms and Research Programs Drive LGND’s Partnerships,2017-08-31 14:36:54 +0000,http://finance.yahoo.com/r/a65c2933-363a-3c61-8535-03c1949a40b3/technology-platforms-research-programs-drive-ligand-pharmaceuticals-partnerships-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"Ligand Pharmaceuticals (LGND) has entered multiple fully funded partnerships by licensing its technology platforms such as OmniAb, Captisol, LTP Technology, and SUREtechnology Platform."
UTHR,UTHR:UW,BBG000BV5663,How Did United Therapeutics’ Orenitram and Unituxin Perform in 2Q17?,2017-08-31 13:08:11 +0000,http://finance.yahoo.com/r/90a99e89-3578-3c74-bbdb-e411b93cfcce/how-did-united-therapeutics-orenitram-and-unituxin-perform-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, United Therapeutics’ (UTHR) Unituxin generated revenues of around $16 million, a 10% decline on a year-over-year (or YoY) basis and an 11% decline on a quarter-over-quarter basis."
UTHR,UTHR:UW,BBG000BV5663,How Did United Therapeutics Perform in 2Q17?,2017-08-31 11:38:59 +0000,http://finance.yahoo.com/r/0f91a23c-08c1-31cc-ac47-81a14ab3c45d/how-did-united-therapeutics-perform-in-2q17?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2Q17, United Therapeutics (UTHR) generated revenues of around $445 million, which reflected ~8% growth on a year-over-year (or YoY) basis and ~20% growth on a quarter-over-quarter basis."
UTHR,UTHR:UW,BBG000BV5663,What Analysts Recommend for United Therapeutics in August 2017,2017-08-30 20:43:37 +0000,http://finance.yahoo.com/r/fd329a45-d69f-3e2c-9162-a21cd16d3697/what-analysts-recommend-for-united-therapeutics-in-august-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In April 2017, United Therapeutics (UTHR) and 3D Systems (DDD) declared their plans to develop solid organ scaffolds for human transplants."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-08-29 12:06:03 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120603493.html?.tsrc=rss,"This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on August 25.  Over the last one-month, outflows of investor capital in ETFs holding UTHR totaled $371 million."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : August 29, 2017",2017-08-29 01:51:30 +0000,http://finance.yahoo.com/r/0044f8b0-b752-3553-b52b-4fce2d29b292/united-therapeutics-corp-value-analysis-nasdaquthr-august-29-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives United Therapeutics Corp. a score of 88. Our analysis is based on comparing United Therapeutics Corp. with the following peers – Eli Lilly and Company, Gilead Sciences, Inc., Teva Pharmaceutical Industries Limited Sponsored ADR, Portola Pharmaceuticals, Inc., Pfizer Inc., Baxter International Inc., Cytokinetics, Incorporated, GlaxoSmithKline plc Sponsored ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-08-24 12:01:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120137946.html?.tsrc=rss,"Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on August 22.  Over the last one-month, outflows of investor capital in ETFs holding UTHR totaled $2.44 billion."
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-08-22 12:04:38 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120438786.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,"Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform",2017-08-21 20:48:00 +0000,https://finance.yahoo.com/news/celularity-inc-accelerates-breakthrough-placental-204800036.html?.tsrc=rss,"---New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration ---Contributions of Capital, ..."
UTHR,UTHR:UW,BBG000BV5663,"Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform",2017-08-21 20:22:00 +0000,https://finance.yahoo.com/news/celularity-inc-accelerates-breakthrough-placental-202200036.html?.tsrc=rss,"---New Biotechnology Company Accelerates the Delivery of Transformative Innovations in Treatments of Cancer, Inflammatory & Degenerative Diseases, and Functional Regeneration ---Contributions of Capital, ..."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : August 21, 2017",2017-08-21 13:03:39 +0000,http://finance.yahoo.com/r/1dc0046a-9787-329c-91de-05151b072eb8/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-uthr-us-august-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics, Mayo Clinic to build lung restoration facility in Florida",2017-08-15 18:03:59 +0000,http://finance.yahoo.com/r/b3dfd0ad-0033-3d57-a52c-488bb618b33d/united-therapeutics-mayo-clinicto-build-lung.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"The facility, expected to take about two years to complete, is part of Mayo's broader plan to make the campus a destination medical facility, the Jacksonville Business Journal reported earlier this year .  It's also part of an expanding focus for Silver Spring-based United Therapeutics (UTHR), which mainly focuses on creating pulmonary hypertension drugs."
UTHR,UTHR:UW,BBG000BV5663,Edited Transcript of UTHR earnings conference call or presentation 27-Jul-17 1:00pm GMT,2017-08-12 23:00:44 +0000,https://finance.yahoo.com/news/edited-transcript-uthr-earnings-conference-163433944.html?.tsrc=rss,Q2 2017 United Therapeutics Corp Earnings Call
UTHR,UTHR:UW,BBG000BV5663,"ETFs with exposure to United Therapeutics Corp. : August 11, 2017",2017-08-11 23:10:37 +0000,http://finance.yahoo.com/r/e4671d94-a77a-33b6-90a7-16797802bd7a/etfs-with-exposure-to-united-therapeutics-corp-august-11-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to United Therapeutics Corp. Here are 5 ETFs with the largest exposure to UTHR-US. Comparing the performance and risk of United Therapeutics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-08-11 12:01:36 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120136695.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
UTHR,UTHR:UW,BBG000BV5663,Stealthy Viruses Take Center Stage In Efforts To Transplant Pig Organs Into People,2017-08-10 18:01:00 +0000,http://finance.yahoo.com/r/c0df6e39-ddf0-3c22-a1f8-a887217dbda4/stealthy-viruses-take-center-stage-in-efforts-to-transplant-pig-organs-into-people?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"Today, in the journal Science, researchers at eGenesis, a Cambridge, Mass.-based biotech, describe work aimed at showing that using new gene-editing technology can deal with one problem that stymied previous attempts at making transplantable organs from pigs."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : August 10, 2017",2017-08-10 13:44:08 +0000,http://finance.yahoo.com/r/db3a1dd4-1bd3-3a28-a6d0-322a22d014ab/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-uthr-us-august-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,See what the IHS Markit Score report has to say about United Therapeutics Corp.,2017-08-09 12:04:32 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120432745.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At 2017 Wedbush PacGrow Healthcare Conference,2017-08-09 10:00:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-present-2017-100000582.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , Aug. 9, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt , Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk,2017-08-05 01:59:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eWqxlUIjv4E/united-therapeutics-corporation-uthr-shares-soar-on-takeover-talk-cm827644,InvestorPlace Stock Market News Stock Advice amp Trading Tips United Therapeutics Corporation NASDAQ UTHR stock surged on Friday as rumors of a takeover surged The company is reportedly being considered as an acquisition by a
UTHR,UTHR:UW,BBG000BV5663,Analysts say a United Therapeutics sale is premature,2017-08-04 22:04:40 +0000,http://finance.yahoo.com/r/090b1829-e942-3f19-b2d2-9b8c474545dd/united-therapeutics-stock-up-9-percent-on-gsk.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Silver Spring-based United Therapeutics Corp.'s stock jumped Friday following a report that GlaxoSmithKline PLC or other drug giants may be looking to acquire it.  According to a report from the Evening Standard in London on Friday , GSK may be eyeing United Therapeutics in a deal worth nearly $9 billion, or $200 a share.  United Therapeutics' share price jumped more than 9 percent on the report from a previous close of $126.96 to open at $138.90."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation (UTHR) Shares Soar on Takeover Talk,2017-08-04 21:08:43 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-uthr-shares-210843508.html?.tsrc=rss,"United Therapeutics Corporation (NASDAQ:UTHR) stock surged on Friday as rumors of a takeover surged.  The company is reportedly being considered as an acquisition by a major pharmaceutical giant, including Gilead Sciences Inc (NASDAQ:GILD), GlaxoSmithKline PLC (NYSE:GSK) and Novartis AG (NYSE:NVS).  GlaxoSmithKline and United Therapeutics both declined to comment on the matter."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Breaks Above 200-Day Moving Average - Bullish for UTHR,2017-08-04 17:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mbFCSsBD2PQ/united-therapeutics-breaks-above-200-day-moving-average-bullish-for-uthr-cm827368,In trading on Friday shares of United Therapeutics Corp Symbol UTHR crossed above their 200 day moving average of 134 76 changing hands as high as 139 10 per share United Therapeutics Corp shares are currently trading up about 7 7 on the day The chart below shows the one year
UTHR,UTHR:UW,BBG000BV5663,Gilead Could Be Making An Acquisition — But It&apos;s Not What You Think,2017-08-04 16:15:05 +0000,http://finance.yahoo.com/r/85b1f35d-463e-30a6-9503-52af91e9b1de/gilead-could-be-making-an-acquisition-but-its-not-what-you-think?src=A00220&yptr=yahoo&.tsrc=rss,"United Therapeutics surged to an 18-week high Friday on reports Gilead, Glaxo and Novartis could be considering takeover bids on it."
UTHR,UTHR:UW,BBG000BV5663,Biotech Movers: Buzz on Potential Suitors Sends United Therapeutics Stock Soaring,2017-08-04 14:43:00 +0000,http://finance.yahoo.com/r/bd89cb5e-38d9-3055-9278-f07f1a700619/biotech-movers-buzz-on-potential-suitors-sends-united-therapeutics-stock-soaring.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"GlaxoSmithKline could be among the suitors for United Therapeutics, the Evening Standard reported."
UTHR,UTHR:UW,BBG000BV5663,"Pre-Market Most Active for Aug 4, 2017 :  ETP, BA, HCLP, OKE, BAC, GPRO, SUN, QQQ, USLV, TLT, UTHR, AAOI",2017-08-04 12:58:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J3g44AyqTH4/pre-market-most-active-for-aug-4-2017-etp-ba-hclp-oke-bac-gpro-sun-qqq-uslv-tlt-uthr-aaoi-cm827070,The NASDAQ 100 Pre Market Indicator is up 5 03 to 5 896 23 The total Pre Market volume is currently 8 234 529 shares traded The following are the most active stocks for the pre market session Energy Transfer Partners L P ETP is unchanged at 20 41 with 1 535
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corp. stock surges 9% on report of possible bids for company,2017-08-04 12:47:13 +0000,http://finance.yahoo.com/r/add22b3c-b97f-32c7-af18-aedfee93fb1b/Story.aspx?guid=C83EE73F-FFCA-431E-94B4-AF25D246805A&siteid=yhoof2&yptr=yahoo&.tsrc=rss,United Therapeutics Corp. shares surged 8.7% premarket on Friday after a news report suggested that major pharmaceutical companies were weighing a bid for it. The Evening Standard report said that Gilead ...
UTHR,UTHR:UW,BBG000BV5663,Morning Movers: Viacom Tumbles on Earnings; United Therapeutics Soars,2017-08-04 12:31:00 +0000,http://finance.yahoo.com/r/df1e834c-9e8e-34ca-a2f4-29e4aad48b94/morning-movers-viacom-tumbles-on-earnings-united-therapeutics-soars-1501849897?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Stocks were headed for a slightly lower open this morning before the release of the July payrolls report. S&P 500 futures have risen 0.1%, while Dow Jones Industrial Average futures have gained 0.3%. Nasdaq ..."
UTHR,UTHR:UW,BBG000BV5663,Robbins Arroyo LLP Is Investigating the Officers and Directors of United Therapeutix Corporation (UTHR) on Behalf of Shareholders,2017-08-03 19:46:00 +0000,https://finance.yahoo.com/news/robbins-arroyo-llp-investigating-officers-194600762.html?.tsrc=rss,Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of United Therapeutics Corporation breached their fiduciary duties to shareholders.
UTHR,UTHR:UW,BBG000BV5663,INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of United Therapeutics Corporation,2017-08-02 14:30:00 +0000,https://finance.yahoo.com/news/investor-alert-law-offices-howard-143000191.html?.tsrc=rss,"Law Offices of Howard G. Smith announces an investigation on behalf of investors of United Therapeutics Corporation , concerning whether the Company misled investors regarding its compliance with applicable healthcare laws."
UTHR,UTHR:UW,BBG000BV5663,"Lifshitz & Miller LLP Announces Investigation of EZCORP, Inc., Flowserve Corporation, Halliburton Company, NCI, Inc., Parkway, Inc., United Therapeutics Corporation and ViewRay, Inc.",2017-08-02 10:46:00 +0000,https://finance.yahoo.com/news/lifshitz-miller-llp-announces-investigation-104600845.html?.tsrc=rss,"NEW YORK , Aug. 2, 2017 /PRNewswire/ -- EZCORP, Inc. (EZPW) Lifshitz & Miller announces investigation on behalf of EZPW investors concerning whether EZPW issued false and misleading statements about its ..."
UTHR,UTHR:UW,BBG000BV5663,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces an Investigation of United Therapeutics Corporation and Encourages Investors with Losses to Contact the Firm,2017-07-31 23:24:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-khang-khang-232400426.html?.tsrc=rss,Khang & Khang LLP announces that it is investigating claims against United Therapeutics Corporation concerning possible violations of federal securities laws.
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm",2017-07-31 21:30:00 +0000,https://finance.yahoo.com/news/united-therapeutics-investor-alert-faruqi-213000530.html?.tsrc=rss,"Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at United Therapeutics Corporation ."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017",2017-07-28 17:35:47 +0000,http://finance.yahoo.com/r/6ecbe250-304d-3c7f-be93-08a53e14068d/united-therapeutics-corp-uthr-us-earnings-analysis-q2-2017-by-the-numbers-july-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis United Therapeutics Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of United Therapeutics Corp. – Eli Lilly and Company, Gilead Sciences, Inc., Baxter International Inc. and GlaxoSmithKline plc Sponsored ADR (LLY-US, GILD-US, BAX-US and GSK-US) that have also reported ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Incurs Loss in Q2, Sales Top",2017-07-28 17:02:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bzuUqbWjWVU/united-therapeutics-uthr-incurs-loss-in-q2-sales-top-cm823404,United Therapeutics Corporation UTHR reported adjusted earnings of 4 41 per share including stock based compensation benefit but excluding charges for the second quarter of 2017 which were better than 4 39 per share in the year ago quarter United Therapeutics said it has set aside
UTHR,UTHR:UW,BBG000BV5663,IMPORTANT INVESTOR ALERT: Lundin Law PC Announces an Investigation of United Therapeutics Corporation,2017-07-28 16:50:00 +0000,https://finance.yahoo.com/news/important-investor-alert-lundin-law-165000980.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against United Therapeutics Corporation concerning possible violations of federal securities laws."
UTHR,UTHR:UW,BBG000BV5663,UTHR SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of United Therapeutics Corporation,2017-07-28 15:14:00 +0000,https://finance.yahoo.com/news/uthr-shareholder-alert-law-offices-151400416.html?.tsrc=rss,The Law Offices of Vincent Wong notifies investors of an investigation concerning whether United Therapeutics Corporation violated federal securities laws.
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Incurs Loss in Q2, Sales Top",2017-07-28 14:57:02 +0000,https://finance.yahoo.com/news/united-therapeutics-uthr-incurs-loss-145702001.html?.tsrc=rss,"United Therapeutics Corporation (UTHR) incurred a loss in Q2. However, stronger sales across the PAH franchise pulled up the top line in the quarter."
UTHR,UTHR:UW,BBG000BV5663,Harwood Feffer LLP Announces Investigation of United Therapeutics Corporation,2017-07-28 14:09:00 +0000,https://finance.yahoo.com/news/harwood-feffer-llp-announces-investigation-140900322.html?.tsrc=rss,"NEW YORK , July 28, 2017 /PRNewswire/ --   Harwood Feffer LLP ( www.hfesq.com ) is investigating potential claims against the board of directors of United Therapeutics Corporation (""United Therapeutics"" ..."
UTHR,UTHR:UW,BBG000BV5663,SHAREHOLDER ALERT: Goldberg Law PC Announces an Investigation of United Therapeutics Corporation,2017-07-28 14:01:00 +0000,https://finance.yahoo.com/news/shareholder-alert-goldberg-law-pc-140100690.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of United Therapeutics Corporation ."
UTHR,UTHR:UW,BBG000BV5663,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of United Therapeutics Corporation -- UTHR",2017-07-28 13:53:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-135300400.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation concerning possible violations of federal securities laws.
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : July 28, 2017",2017-07-28 13:42:23 +0000,http://finance.yahoo.com/r/373d1635-cef7-3b7e-b9d6-b1c90d2dab99/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-uthr-us-july-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics would have had its strongest quarter ever. Except for this.,2017-07-28 12:13:04 +0000,http://finance.yahoo.com/r/9ef050c9-2b0a-30ec-82c8-7042f538dafa/united-therapeutics-would-have-had-its-strongest.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"United Therapeutics Corp. swung from the black into the red in the second quarter, due mostly to the company's decision to set aside $210 million for a possible settlement agreement for a Justice Department investigation.  In a recent regulatory filing, the Silver Spring biotech revealed it received a Department of Justice subpoena in May 2016.  It came as part of an investigation into whether United Therapeutics (UTHR) violated the Federal Anti-Kickback Statute and Federal False Claims Act by supporting nonprofit organizations that provide financial assistance to patients — claims the company disputes."
UTHR,UTHR:UW,BBG000BV5663,[$$] United Therapeutics in Settlement Talks With Justice Department,2017-07-28 06:04:12 +0000,http://finance.yahoo.com/r/9e1d0324-d7e9-3499-bedc-9599778ce182/united-therapeutics-in-settlement-talks-with-justice-department-1501162542?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
UTHR,UTHR:UW,BBG000BV5663,UNITED THERAPEUTICS CORPORATION (UTHR) INVESTOR ALERT: Legal Investigation for Potential Securities Law Violations,2017-07-28 01:37:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-uthr-investor-013700584.html?.tsrc=rss,Girard Gibbs LLP is investigating potential claims on behalf of investors of United Therapeutics Corporation regarding possible securities law violations.
UTHR,UTHR:UW,BBG000BV5663,IMPORTANT INVESTOR ALERT: Khang & Khang LLP Announces an Investigation of United Therapeutics Corporation and Encourages Investors with Losses to Contact the Firm,2017-07-27 23:28:00 +0000,https://finance.yahoo.com/news/important-investor-alert-khang-khang-232800126.html?.tsrc=rss,Khang & Khang LLP announces that it is investigating claims against United Therapeutics Corporation concerning possible violations of federal securities laws.
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In United Therapeutics Corporation To Contact The Firm",2017-07-27 22:52:00 +0000,https://finance.yahoo.com/news/united-therapeutics-investor-alert-faruqi-225200789.html?.tsrc=rss,"NEW YORK , July 27, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at United Therapeutics Corporation (""United Therapeutics"" ..."
UTHR,UTHR:UW,BBG000BV5663,IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of United Therapeutics Corporation,2017-07-27 21:36:00 +0000,https://finance.yahoo.com/news/important-shareholder-alert-lundin-law-213600517.html?.tsrc=rss,"Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against United Therapeutics Corporation concerning possible violations of federal securities laws."
UTHR,UTHR:UW,BBG000BV5663,"Bragar Eagel & Squire, P.C. Is Investigating United Therapeutics Corporation (UTHR) on Behalf of Stockholders and Encourages Investors to Contact the Firm",2017-07-27 21:30:00 +0000,https://finance.yahoo.com/news/bragar-eagel-squire-p-c-213000766.html?.tsrc=rss,"Bragar Eagel & Squire, P.C. is investigating potential claims against United Therapeutics Corporation . Our investigation concerns whether United Therapeutics has violated the federal securities laws and/or engaged in other unlawful business practices."
UTHR,UTHR:UW,BBG000BV5663,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of United Therapeutics Corporation (UTHR)",2017-07-27 20:36:00 +0000,https://finance.yahoo.com/news/shareholder-alert-bronstein-gewirtz-grossman-203600109.html?.tsrc=rss,"NEW YORK , July 27, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of United Therapeutics Corporation (""United ..."
UTHR,UTHR:UW,BBG000BV5663,Biotech Fever Cools As These Players Dip On Longer-Term Views,2017-07-27 20:29:27 +0000,http://finance.yahoo.com/r/e0e84444-b923-3d34-8f46-b359808f2173/biotech-fever-cools-as-these-players-dip-on-longer-term-views?src=A00220&yptr=yahoo&.tsrc=rss,"Biotech stocks toppled midday Thursday, in-line with broader indexes, and included pitfalls from large players like Vertex, United and Spark."
UTHR,UTHR:UW,BBG000BV5663,INVESTOR ALERT: Goldberg Law PC Announces an Investigation of United Therapeutics Corporation,2017-07-27 20:22:00 +0000,https://finance.yahoo.com/news/investor-alert-goldberg-law-pc-202200443.html?.tsrc=rss,"Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of United Therapeutics Corporation ."
UTHR,UTHR:UW,BBG000BV5663,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of United Therapeutics Corporation - (UTHR),2017-07-27 20:21:00 +0000,https://finance.yahoo.com/news/shareholder-alert-pomerantz-law-firm-202100981.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / July 27, 2017 / Pomerantz LLP is investigating claims on behalf of investors of United Therapeutics Corporation (''United Therapeutics'' or the ''Company'') (NASDAQ: UTHR). ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics reports 2Q loss,2017-07-27 20:17:24 +0000,https://finance.yahoo.com/news/united-therapeutics-reports-2q-loss-102411239.html?.tsrc=rss,"The Silver Spring, Maryland-based company said it had a loss of $1.25 per share. The results missed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ..."
UTHR,UTHR:UW,BBG000BV5663,EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against United Therapeutics Corporation - UTHR,2017-07-27 20:09:00 +0000,https://finance.yahoo.com/news/equity-alert-rosen-law-firm-200900262.html?.tsrc=rss,"Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of United Therapeutics Corporation resulting from allegations that United Therapeutics may have issued materially misleading business information to the investing public."
UTHR,UTHR:UW,BBG000BV5663,Glancy Prongay & Murray LLP Commences Investigation on Behalf of United Therapeutics Corporation Investors,2017-07-27 19:21:00 +0000,https://finance.yahoo.com/news/glancy-prongay-murray-llp-commences-192100255.html?.tsrc=rss,Glancy Prongay & Murray LLP announces an investigation on behalf of United Therapeutics Corporation investors concerning the Company and its officers’ possible violations of federal securities laws.
UTHR,UTHR:UW,BBG000BV5663,[$$] United Therapeutics in Settlement Talks With Justice Department,2017-07-27 17:59:11 +0000,http://finance.yahoo.com/r/9e1d0324-d7e9-3499-bedc-9599778ce182/united-therapeutics-in-settlement-talks-with-justice-department-1501162542?mod=yahoo_hs&yptr=yahoo&.tsrc=rss,United Therapeutics has set aside $210 million for a possible settlement of a U.S. Justice Department investigation of whether the company’s contributions to patient-assistance charity groups violate federal ...
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics, DOJ in Possible Settlement Over Drug Contributions",2017-07-27 14:32:00 +0000,http://finance.yahoo.com/r/e5bca2d8-63cd-3ed1-8345-f9c3d593538a/united-therapeutics-doj-in-possible-settlement-over-drug-contributions.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Justice Department is investigating the company's charitable contributions for kickbacks and false claims.
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports Second Quarter 2017 Financial Results,2017-07-27 10:00:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-reports-second-100000402.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 27, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June 30, ..."
UTHR,UTHR:UW,BBG000BV5663,UTHR Crosses Above Average Analyst Target,2017-07-26 13:59:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p1pD_UeykrE/uthr-crosses-above-average-analyst-target-cm821574,In recent trading shares of United Therapeutics Corp Symbol UTHR have crossed above the average analyst 12 month target price of 131 78 changing hands for 132 38 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
UTHR,UTHR:UW,BBG000BV5663,10 Ben Graham-Inspired Stocks For Value's Eventual Turn,2017-07-25 13:05:00 +0000,http://finance.yahoo.com/r/628343c6-85f6-33e7-86d1-a7ff7b926eaa/10-ben-graham-inspired-stocks-for-values-eventual-turn?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,Value investing is by nature contrarian and the underperformance of value stocks over the past few years could be a opportunity for long-term disciplined investors. Here are some of the deepest value stocks in the market using the strategy of legendary investor Ben Graham.
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation to Report Second Quarter 2017 Financial Results Before The Market Opens on Thursday, July 27, 2017",2017-07-21 16:30:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-report-second-163000786.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C. , July 21, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its second quarter 2017 financial ..."
UTHR,UTHR:UW,BBG000BV5663,Upcoming Catalysts Could Boost United Therapeutics: OpCo,2017-07-19 14:56:00 +0000,http://finance.yahoo.com/r/65cde17f-bc9c-3a82-8047-6d37acbe3237/upcoming-catalysts-could-boost-united-therapeutics-opco-1500476186?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"Oppenheimer's Hartaj Singh reitearted his bullish stance on United Therapeutics (  UTHR) on Wednesday, writing that upcoming catalysts in the next six to 12 months are critical to the stock, and, if they go well, could lead to it re-rating.  The most important catalyst may be the FREEDOM-EV Phase 3 pivotal trial of Orenitram in pulmonary arterial hypertension."
UTHR,UTHR:UW,BBG000BV5663,"E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day",2017-07-12 15:51:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/o8iQw7xZ_wQ/etrade-financial-statoil-arena-pharmaceuticals-johnson-johnson-and-united-therapeutics-highlighted-as-zacks-bull-and-bear-of-the-day-cm815144,For Immediate Release Chicago IL July 12 2017 Zacks Equity Research highlights E Trade Financial NASDAQ ETFC Free Report as the Bull of the Day Statoil NYSE STO Free Report as the Bear of the Day In addition Zacks Equity Research provides analysis on
UTHR,UTHR:UW,BBG000BV5663,"E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day",2017-07-12 13:30:01 +0000,https://finance.yahoo.com/news/e-trade-financial-statoil-arena-133001464.html?.tsrc=rss,"E*Trade Financial, Statoil, Arena Pharmaceuticals, Johnson & Johnson and United Therapeutics highlighted as Zacks Bull and Bear of the Day"
UTHR,UTHR:UW,BBG000BV5663,Here's Why Arena Pharmaceuticals (ARNA) Stock is Skyrocketing Today,2017-07-11 21:46:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_BHAfDrqRKM/heres-why-arena-pharmaceuticals-arna-stock-is-skyrocketing-today-cm814723,On Tuesday shares of biopharmaceutical company Arena Pharmaceuticals ARNA are skyrocketing up about 41 to 26 10 per share in afternoon trading after it reported positive mid stage trial results for one of its drugs The stock was up 45 in pre market trading Arena said that within
UTHR,UTHR:UW,BBG000BV5663,"Arena's Ralinepag Positive in Phase II PAH Study, Shares Up",2017-07-11 16:47:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Lar0smuy3Ho/arenas-ralinepag-positive-in-phase-ii-pah-study-shares-up-cm814511,Arena Pharmaceuticals Inc s ARNA shares surged 41 3 in after market trading 160 on Monday after the company announced that a phase II study evaluating its key pipeline candidate ralinepag in pulmonary arterial hypertension PAH met its primary endpoint Also the company plans
UTHR,UTHR:UW,BBG000BV5663,7 of the Worst-Performing Stocks in Gurus' Portfolios,2017-07-07 21:44:28 +0000,https://finance.yahoo.com/news/7-worst-performing-stocks-gurus-214428579.html?.tsrc=rss,These companies had a negative 6-month performance
UTHR,UTHR:UW,BBG000BV5663,Cardiome's Partner SteadyMed Submits NDA for PAH Injection,2017-07-04 15:44:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JYh_3d6bzBg/cardiomes-partner-steadymed-submits-nda-for-pah-injection-cm811582,Cardiome Pharma Corp CRME announced that its partner SteadyMed Ltd STDY has submitted a new drug application NDA to the FDA for its lead candidate Trevyent treprostinil injection for treatment of pulmonary arterial hypertension PAH The company plans to launch the product in mid
UTHR,UTHR:UW,BBG000BV5663,What Analysts Recommend for United Therapeutics in June 2017,2017-07-04 14:37:39 +0000,http://finance.yahoo.com/r/8a7b600d-8566-38d4-b274-1e11694167e7/what-analysts-recommend-for-united-therapeutics-in-june-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,Thirteen analysts covered United Therapeutics in June 2017. Two analysts recommended a “strong buy.”
UTHR,UTHR:UW,BBG000BV5663,Cardiome&apos;s Partner SteadyMed Submits NDA for PAH Injection,2017-07-04 13:16:01 +0000,https://finance.yahoo.com/news/cardiome-apos-partner-steadymed-submits-131601931.html?.tsrc=rss,"Cardiome Pharma Corp. (CRME) announced that its partner SteadyMed Ltd. (STDY) has submitted a new drug application (NDA) to the FDA for its lead candidate, Trevyent (treprostinil injection), for treatment of pulmonary arterial hypertension (PAH)."
UTHR,UTHR:UW,BBG000BV5663,Adcirca May Witness Gradual Decline in Revenues,2017-07-04 13:08:28 +0000,http://finance.yahoo.com/r/5c089216-474e-3d7e-9f53-691820f57790/adcirca-may-witness-gradual-decline-in-revenues?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, Unituxin reported revenues of ~$62.5 million compared to $20.5 million in 2015."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics’ Orenitram May Show Revenue Growth in 2017,2017-07-04 11:38:50 +0000,http://finance.yahoo.com/r/7c33e622-55c2-33ce-b9bc-895ada9ee839/united-therapeutics-orenitram-may-show-revenue-growth-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics’ (UTHR) Orenitram reported revenues of ~$157.0 million, which reflected ~33.0% growth year-over-year."
UTHR,UTHR:UW,BBG000BV5663,What Can We Expect from United Therapeutics’ Tyvaso in 2017?,2017-07-03 14:39:48 +0000,http://finance.yahoo.com/r/38ea1ca5-41b6-3382-b650-5cb6f93a12e8/what-can-we-expect-from-united-therapeutics-tyvaso-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics’ (UTHR) Tyvaso reported revenues of ~$404.0 million, which reflected an ~15.0% decline year-over-year."
UTHR,UTHR:UW,BBG000BV5663,How Is United Therapeutics’ Remodulin Positioned in 2017?,2017-07-03 13:10:54 +0000,http://finance.yahoo.com/r/54cac33d-ddc4-3b15-b9fc-008e1a50e5de/how-is-united-therapeutics-remodulin-positioned-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics’ (UTHR) Remodulin reported revenues of ~$602.3 million, which reflected ~5.0% year-over-year growth."
UTHR,UTHR:UW,BBG000BV5663,How United Therapeutics Is Expected to Perform in 2017,2017-07-03 11:42:39 +0000,http://finance.yahoo.com/r/bd726e7a-99bf-33e9-9972-5e0fe2f95e17/how-united-therapeutics-is-expected-to-perform-in-2017?utm_source=yahoo&utm_medium=feed&yptr=yahoo&.tsrc=rss,"In 2016, United Therapeutics (UTHR) reported ~$1.6 billion in revenues, reflecting ~9.0% YoY growth. In 1Q17, UTHR generated ~$370.0 million in revenues—an ~9.0% quarter-over-quarter decline."
UTHR,UTHR:UW,BBG000BV5663,Friday's ETF with Unusual Volume: LRGF,2017-06-30 18:42:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kWO3JtwB-jY/fridays-etf-with-unusual-volume-lrgf-cm810695,The iShares Edge MSCI Multifactor USA ETF LRGF is seeing unusually high volume in afternoon trading Friday with over 628 000 shares traded versus three month average volume of about 152 000 Shares of LRGF were up about 0 2 on the day Components of that ETF with the highest volume
UTHR,UTHR:UW,BBG000BV5663,Arena Ends Study on Extended Release Formulation of PAH Drug,2017-06-30 17:42:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8UuEZ6Hy1m0/arena-ends-study-on-extended-release-formulation-of-pah-drug-cm810652,ARena Pharmaceuticals Inc ARNA announced that it has completed an early stage study comparing the once daily extended release XR formulation of its experimental pulmonary arterial hypertension PAH candidate ralinepag with its twice daily immediate release IR formulation It is to
UTHR,UTHR:UW,BBG000BV5663,[$$] Biotech Blazes Higher,2017-06-24 04:15:00 +0000,http://finance.yahoo.com/r/b2c722c2-a95e-391a-b0f4-d8e9c0a109e6/biotech-blazes-higher-1498277748?mod=yahoobarrons&ru=yahoo&yptr=yahoo&.tsrc=rss,"It takes just one match to start a fire, but last week the biotech sector got two.  Investors should take care not to get burned.  The sector got a boost not only from the Senate’s health-care plan, which made nary a mention of the high cost of drugs, but also from a draft of an executive order by President Donald Trump, which appeared to remove the threat of imminent action to rein in prices."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Reaches Analyst Target Price,2017-06-22 14:20:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FkpCymDbwks/united-therapeutics-reaches-analyst-target-price-cm806730,In recent trading shares of United Therapeutics Corp Symbol UTHR have crossed above the average analyst 12 month target price of 131 78 changing hands for 131 93 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
UTHR,UTHR:UW,BBG000BV5663,Argan and Sturm Ruger Show High Profit and Low Debt,2017-06-20 22:06:51 +0000,https://finance.yahoo.com/news/argan-sturm-ruger-show-high-220651521.html?.tsrc=rss,Five recommendations
UTHR,UTHR:UW,BBG000BV5663,Silver Spring tissue regeneration company raises $12 million,2017-06-14 17:20:14 +0000,http://finance.yahoo.com/r/aa0ee011-352f-31ec-a860-de31b65ee5f9/silver-spring-tissue-regeneration-company-raises.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"HighCape Partners, a New York equity fund and majority owner of Aziyo, led the funding round for the local company, which creates customized human tissue products for use in orthopedic, spinal, sports medicine and dermal surgeries.  Several of its products are allografts — or tissue grafts from donors — for bone repair, ligament replacement and skin grafts."
UTHR,UTHR:UW,BBG000BV5663,"Your first trade for Friday, June 9",2017-06-09 13:38:13 +0000,https://finance.yahoo.com/news/first-trade-friday-june-9-133813966.html?.tsrc=rss,The &quot;Fast Money&quot; traders give their final trades of the day.
UTHR,UTHR:UW,BBG000BV5663,"“Fast Money” final trades: KSU, SNAP, and more",2017-06-08 21:59:00 +0000,https://finance.yahoo.com/video/fast-money-final-trades-ksu-215900375.html?.tsrc=rss,"The “Fast Money” traders discuss their final trades for the day including Kansas City Southern, Snap Inc, S&P Retail ETF and United Therapeutics."
UTHR,UTHR:UW,BBG000BV5663,Here's how the founder of X Prize says you can invest in ...,2017-06-07 21:39:00 +0000,https://finance.yahoo.com/video/heres-founder-x-prize-says-213900097.html?.tsrc=rss,"CNBC's Bob Pisani talks to Peter Diamandis, executive chairman of the X Prize Foundation, talks about investing in space technology and human longevity and how it may play out in the market."
UTHR,UTHR:UW,BBG000BV5663,"ETFs with exposure to United Therapeutics Corp. : June 2, 2017",2017-06-02 18:36:14 +0000,http://finance.yahoo.com/r/d53e999f-0cda-3ef1-80d9-c3825cb33b42/etfs-with-exposure-to-united-therapeutics-corp-june-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to United Therapeutics Corp. Here are 5 ETFs with the largest exposure to UTHR-US. Comparing the performance and risk of United Therapeutics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : June 2, 2017",2017-06-02 12:42:01 +0000,http://finance.yahoo.com/r/b3e7c3d9-10fe-3a78-bbdd-daef08af2bc9/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-uthr-us-june-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for United Therapeutics Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Jefferies 2017 Global Healthcare Conference,2017-05-31 10:00:00 +0000,https://finance.yahoo.com/news/united-therapeutics-corporation-present-jefferies-100000151.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., May 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) announced today that James Edgemond, Chief Financial Officer and Treasurer of United Therapeutics, will provide an overview and update on the company's business at the Jefferies 2017 Global Healthcare Conference in New York, New York.  The presentation will take place on Tuesday, June 6, 2017, at 3:30 PM Eastern Time, and can be accessed via a live webcast on the United Therapeutics website at http://www.unither.com under the ""Investors"" tab in the ""Events and Presentations"" section.  An archived, recorded version of the presentation will be available approximately twenty-four hours after the presentation ends and can be accessed at the same location for 90 days."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics reworks deal ahead of a key patent's expiration,2017-05-19 10:50:12 +0000,http://finance.yahoo.com/r/a4513009-3060-3dc0-86f2-0551c23ec0d6/united-therapeutics-reworks-deal-ahead-of-a-key.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Silver Spring drugmaker United Therapeutics Corp. extended an exclusive license with drug giant Eli Lilly & Co. to cover its pulmonary hypertension drug Adcirca, which will lose part of its patent protection later this year.  The active ingredient in Adcirca is tadalafil, also the active pharmaceutical ingredient in Cialis, which is marketed by Eli Lilly (LLY) to treat erectile dysfunction.  United Therapeutics (UTHR), in 2008, acquired the commercial rights to Adcirca from Eli Lilly for the treatment of pulmonary hypertension — but one of three patents held by the larger company that protects Adcirca is set to expire in November."
UTHR,UTHR:UW,BBG000BV5663,Blog Coverage: Ionis Pharma Reported Positive Phase III Results in Patients with Familial Amyloid Polyneuropathy,2017-05-16 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-ionis-pharma-reported-121500042.html?.tsrc=rss,"Upcoming AWS Coverage on United Therapeutics Post-Earnings Results LONDON, UK / ACCESSWIRE / May 16, 2017 / Active Wall St. blog coverage looks at the headline from Ionis Pharmaceutical, Inc. (NASDAQ: ..."
UTHR,UTHR:UW,BBG000BV5663,"ETFs with exposure to United Therapeutics Corp. : May 15, 2017",2017-05-15 20:50:56 +0000,http://finance.yahoo.com/r/b159de81-ab0c-3606-a8df-c91e20dfb985/etfs-with-exposure-to-united-therapeutics-corp-may-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to United Therapeutics Corp. Here are 5 ETFs with the largest exposure to UTHR-US. Comparing the performance and risk of United Therapeutics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update,2017-05-12 12:30:00 +0000,http://finance.yahoo.com/news/steadymed-reports-first-quarter-2017-123000174.html?.tsrc=rss,Raised $28.2 Million in Net Proceeds in a Private Placement. Received a Favorable IPR Ruling Invalidating United Therapeutics’‘ 393 Patent. Completed a Clinical Validation Study for Trevyent ®.
UTHR,UTHR:UW,BBG000BV5663,"ETFs with exposure to United Therapeutics Corp. : May 2, 2017",2017-05-02 20:48:18 +0000,http://finance.yahoo.com/r/8659002d-eeb0-3772-a28b-ef669f691839/etfs-with-exposure-to-united-therapeutics-corp-may-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to United Therapeutics Corp. Here are 5 ETFs with the largest exposure to UTHR-US. Comparing the performance and risk of United Therapeutics Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017",2017-05-01 14:27:16 +0000,http://finance.yahoo.com/r/4aeae456-43a2-318b-9990-e6a60441a5fe/united-therapeutics-corp-uthr-us-earnings-analysis-q1-2017-by-the-numbers-may-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis United Therapeutics Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of United Therapeutics Corp. – Eli Lilly and Company, Baxter International Inc., Cytokinetics, Incorporated and GlaxoSmithKline plc Sponsored ADR (LLY-US, BAX-US, CYTK-US and GSK-US) that have also reported for ... Read more
<b>(Read more...)</b>"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics' Martine Rothblatt saw pay jump last year amid executive shakeup,2017-05-01 14:02:26 +0000,http://finance.yahoo.com/r/77587e57-fec8-3e62-b000-d9b3dd75b1a7/united-therapeutics-martine-rothblatt-saw-pay-jump.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"United Therapeutics Corp. CEO and founder Martine Rothblatt made $15.5 million in 2016, a healthy jump in her compensation in a year that saw an executive management shakeup in which Rothblatt became sole CEO of the Silver Spring drug maker.  Co-CEO and President Roger Jeffs resigned from the company in June 2016 .  Michael Benkowitz was promoted to president and chief operating officer upon the resignations and received $5.3 million in compensation last year."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics partners with 3-D printer to make human organs,2017-04-28 15:51:58 +0000,http://finance.yahoo.com/r/28ef5941-f412-3f6a-bc76-3e78b1670096/united-therapeutics-partners-with-3-d-printer-to.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Silver Spring-based United Therapeutics Corp. has been clear about its ambitions to build an unlimited supply of certain transplantable organs.  Now, founder Martine Rothblatt said the company's new multiyear collaboration with a 3-D bioprinting company, announced Wednesday, takes it a big step toward that goal.  United Therapeutics (UTHR), which now mostly develops and sells pulmonary hypertension drugs, announced a development agreement to create ""solid-organ scaffolds"" for human transplants with Rock Hill, South Carolina-based 3D Systems (DDD)."
UTHR,UTHR:UW,BBG000BV5663,Edited Transcript of UTHR earnings conference call or presentation 26-Apr-17 1:00pm GMT,2017-04-28 12:00:50 +0000,http://finance.yahoo.com/news/edited-transcript-uthr-earnings-conference-210246307.html?.tsrc=rss,Q1 2017 United Therapeutics Corp Earnings Call
UTHR,UTHR:UW,BBG000BV5663,InPlay from Briefing.com,2017-04-28 00:29:32 +0000,http://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces $250 Million Share Repurchase Program,2017-04-28 00:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-announces-250-million-000000980.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 27, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that its Board of Directors authorized the repurchase of up to $250 million of the company's common stock.  Purchases may be made in the open market, accelerated share repurchases or in privately negotiated transactions from time to time as determined by United Therapeutics' management and in accordance with the requirements of the U.S. Securities and Exchange Commission and the Board's authorization, which includes a maximum purchase price per share acquired under the program.  ""We are pleased to continue our track record of returning value to our shareholders via stock repurchases,"" remarked Martine Rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss",2017-04-27 17:30:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QIQtwvyhvpw/united-therapeutics-uthr-q1-earnings-beat-sales-miss-cm780452,United Therapeutics Corporation UTHR reported adjusted earnings of 3 89 per share including stock based compensation benefit for the first quarter of 2017 which beat the Zacks Consensus Estimate of 3 54 by 9 89 However quarterly revenues of 370 5 million missed the Zacks
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Q1 Earnings Beat, Sales Miss",2017-04-27 15:29:03 +0000,http://finance.yahoo.com/news/united-therapeutics-uthr-q1-earnings-152903571.html?.tsrc=rss,United Therapeutics Corporation (UTHR) reported adjusted earnings of $3.89 per share (including stock-based compensation benefit) for the first quarter of 2017
UTHR,UTHR:UW,BBG000BV5663,Blog Coverage3D Systems and United Therapeutics Partner to Develop 3D Bioprinted Lungs,2017-04-27 12:15:00 +0000,http://finance.yahoo.com/news/blog-coverage3d-systems-united-therapeutics-121500223.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / April 27, 2017 / Active Wall St. blog coverage looks at the headline from the manufacturer of 3D printer 3D Systems Corp. (NYSE: DDD ) and Biotech Company United Therapeutics ..."
UTHR,UTHR:UW,BBG000BV5663,These Greater Washington companies may be most affected by Trump's tax reform,2017-04-26 19:39:41 +0000,http://finance.yahoo.com/r/56283588-a927-327b-973e-a4d1bd5505cf/these-greater-washington-companies-may-be-most.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"President Donald Trump introduced his much-anticipated tax reform plan  Wednesday, aimed at simplifying the tax code for individuals and lowering tax rates for businesses.  Key provisions of the proposal include paring down the number of tax brackets for wage earners from seven to three — of 10 percent, 25 percent and 35 percent — and a lowering of corporate tax rates from 35 percent to 15 percent.  The Trump document has one line that reads, “Territorial tax system to level the playing field for American companies.” Ostensibly, that would mean taxing U.S. companies only on profits earned in the United States instead of assessing a tax on all their profits earned around the globe, CNN reported."
UTHR,UTHR:UW,BBG000BV5663,3D Systems signs 'bioprinting' agreement to eventually create human organs,2017-04-26 16:32:59 +0000,http://finance.yahoo.com/r/3158ac62-4897-38f9-8548-00a45cc2f53d/3d-systems-signs-bioprinting-agreement-to.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"3D Systems is teaming up with a Maryland biotech company to eventually “print” the outline of human organs as the first step in creating lungs and other organs from a person’s own cells.  The agreement is between United Therapeutics Corp. (UTHR) and Rock Hill-based 3D Systems (DDD).  Martine Rothblatt, CEO of United Therapeutics, says the goal is to manufacture organs from human cells that can be transplanted into patients."
UTHR,UTHR:UW,BBG000BV5663,"Earnings Reaction History: United Therapeutics Corporation, 50.0% Follow-Through Indicator, 4.5% Sensitive",2017-04-26 11:03:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5GoUpquGkOY/earnings-reaction-history-united-therapeutics-corporation-500-follow-through-indicator-45-sensitive-cm779225,Expected Earnings Release 04 26 2017 PremarketExpected Earnings Release 04 26 2017 Premarket Avg Extended Hours Dollar Volume 891 635Avg Extended Hours Dollar Volume 891 635 United Therapeutics Corporation UTHR is due to issue its quarterly earnings report in the
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats 1Q profit forecasts,2017-04-26 10:10:35 +0000,http://finance.yahoo.com/news/united-therapeutics-beats-1q-profit-101035911.html?.tsrc=rss,"On a per-share basis, the Silver Spring, Maryland-based company said it had profit of $3.89. The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment ..."
UTHR,UTHR:UW,BBG000BV5663,3D Systems and United Therapeutics Announce Bioprinting Agreement,2017-04-26 10:00:00 +0000,http://finance.yahoo.com/news/3d-systems-united-therapeutics-announce-100000085.html?.tsrc=rss,"ROCK HILL, S.C. and SILVER SPRING, Md., April 26, 2017 /PRNewswire/ -- 3D Systems (DDD) and United Therapeutics Corporation (UTHR) today announced plans to develop solid-organ scaffolds for human transplants.  The multi-year collaboration and development agreement combines the 3D printing and precision healthcare expertise of 3D Systems with the regenerative medicine and organ manufacturing capabilities of United Therapeutics.  3D Systems will collaborate with United Therapeutics and its organ manufacturing and transplantation-focused subsidiary, Lung Biotechnology PBC.  The agreement focuses on development of 3D printing systems for solid-organ scaffolds, beginning with lung scaffolds."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports First Quarter 2017 Financial Results,2017-04-26 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-reports-first-100000632.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 26, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March 31, ..."
UTHR,UTHR:UW,BBG000BV5663,Oversold Conditions For United Therapeutics (UTHR),2017-04-25 22:03:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cOroNlhhxjQ/oversold-conditions-for-united-therapeutics-uthr-cm779087,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
UTHR,UTHR:UW,BBG000BV5663,"Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More",2017-04-25 13:08:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ghSfv9yzOB4/drug-stocks-q1-earnings-releases-on-apr-26-amgn-gsk-more-cm778424,The Q1 earnings season is in full swing and we believe this quarter is on track to see the highest growth in almost three years According to the Earnings Preview report 95 S amp P 500 members accounting for 24 9 of the index s total market capitalization have reported results as of Apr
UTHR,UTHR:UW,BBG000BV5663,"Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More",2017-04-25 10:50:10 +0000,http://finance.yahoo.com/news/drug-stocks-q1-earnings-releases-105010141.html?.tsrc=rss,Here we have four pharma companies that are set to report first-quarter results on Apr 26. Let&apos;s see how things are shaping up for this quarter.
UTHR,UTHR:UW,BBG000BV5663,"Rising Revenue and Earnings: Mistubishi Financial, United Therapeutics",2017-04-19 19:58:09 +0000,http://finance.yahoo.com/news/rising-revenue-earnings-mistubishi-financial-195809566.html?.tsrc=rss,Companies have strong 5-year figures
UTHR,UTHR:UW,BBG000BV5663,Add Up The Parts: FXH Could Be Worth $68,2017-04-19 14:03:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DKnoyLHeJVA/add-up-the-parts-fxh-could-be-worth-68-cm775699,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Report First Quarter 2017 Financial Results Before The Market Opens On Wednesday, April 26, 2017",2017-04-19 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-report-first-100000303.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 19, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its first quarter 2017 financial results ..."
UTHR,UTHR:UW,BBG000BV5663,"PolarityTE(TM), Inc. Recruits Key Additions to Management",2017-04-18 12:30:00 +0000,http://finance.yahoo.com/news/polarityte-tm-inc-recruits-key-123000282.html?.tsrc=rss,"PolarityTE™, Inc. announces the recruitment of six new members to its growing team with specific expertise and experience in government and defense contracts, intellectual property and FDA legal strategy, ..."
UTHR,UTHR:UW,BBG000BV5663,5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates,2017-04-17 18:53:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j9W4NfDGcZU/5-major-drug-stocks-likely-to-beat-q1-earnings-estimates-cm774773,Pharma and biotech stocks had a difficult 2016 fraught with headwinds mainly related to drug pricing issues Though the drug pricing issues still persist the industry has nonetheless picked up backed by strong results FDA approvals success of new products and significant contributions
UTHR,UTHR:UW,BBG000BV5663,5 Major Drug Stocks Likely to Beat Q1 Earnings Estimates,2017-04-17 17:03:05 +0000,http://finance.yahoo.com/news/5-major-drug-stocks-likely-170305134.html?.tsrc=rss,2017 is expected to be a strong year for drug stocks.
UTHR,UTHR:UW,BBG000BV5663,"Company News for April 04, 2017",2017-04-04 16:26:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OCGnQm3n-fM/company-news-for-april-04-2017-cm769605,160 160 160 Shares of DryShips DRYS plunged 19 after the company entered into an agreement to sell as much as 226 million in common stock to financing source Kalani Investments Limited 160 160 Volkswagen AG s VLKAY shares declined 1 1 after a German court rebuffed
UTHR,UTHR:UW,BBG000BV5663,"Company News for April 04, 2017",2017-04-04 14:31:02 +0000,http://finance.yahoo.com/news/company-news-april-04-2017-143102509.html?.tsrc=rss,"Companies in the News are: DRYS,VW,CAT,UTHR"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Tanks, Remodulin Pump Launch Delayed",2017-04-04 13:39:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bEXBWxoB3r4/united-therapeutics-tanks-remodulin-pump-launch-delayed-cm769423,United Therapeutics Corporation UTHR shares plunged around 9 on Monday after the company announced that regulatory issues will delay the planned U S launch of RemoSynch an implantable pump for delivering Remodulin The company now expects to launch RemoSynch sometime in 2018 against the
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Tanks, Remodulin Pump Launch Delayed",2017-04-04 11:02:11 +0000,http://finance.yahoo.com/news/united-therapeutics-tanks-remodulin-pump-110211380.html?.tsrc=rss,United Therapeutics Corporation (UTHR) shares plunged around 9% on Monday after the company announced that regulatory issues will delay the planned U.S. launch of RemoSynch - an implantable pump for delivering Remodulin
UTHR,UTHR:UW,BBG000BV5663,"Gainers & Losers Of The Day: CYCC, NVCR, STDY, ACOR, OREX...",2017-04-04 02:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KtGXlU-ylRw/gainers--losers-of-the-day-cycc-nvcr-stdy-acor-orex-20170404-00060,"Gainers & Losers Of The Day: CYCC, NVCR, STDY, ACOR, OREX..."
UTHR,UTHR:UW,BBG000BV5663,"Why DryShips, United Therapeutics, and Fiat Chrysler Automobiles Slumped Today",2017-04-03 22:36:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VAsoyijoxQ4/why-dryships-united-therapeutics-and-fiat-chrysler-automobiles-slumped-today-cm769285,Monday was a slow start to the week for the stock market and major market benchmarks lost modest amounts of ground as investors paused following a strong first quarter performance to start 2017 Earnings season is about to begin again and the onus will be on companies to continue
UTHR,UTHR:UW,BBG000BV5663,"Why DryShips, United Therapeutics, and Fiat Chrysler Automobiles Slumped Today",2017-04-03 20:52:27 +0000,http://finance.yahoo.com/r/7efe7908-2cc8-3bb8-8c17-da142d4e5d28/why-dryships-united-therapeutics-and-fiat-chrysler.aspx?yptr=yahoo&.tsrc=rss,These stocks helped lead the market lower. Find out why.
UTHR,UTHR:UW,BBG000BV5663,"Why DryShips, United Therapeutics, and Fiat Chrysler Automobiles Slumped Today",2017-04-03 20:52:27 +0000,https://www.fool.com/investing/2017/04/03/why-dryships-united-therapeutics-and-fiat-chrysler.aspx,"Why DryShips, United Therapeutics, and Fiat Chrysler Automobiles Slumped Today"
UTHR,UTHR:UW,BBG000BV5663,UTHR Crosses Below Key Moving Average Level,2017-04-03 16:38:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WaM4jqCZ8Ns/uthr-crosses-below-key-moving-average-level-cm769061,In trading on Monday shares of United Therapeutics Corp Symbol UTHR crossed below their 200 day moving average of 131 30 changing hands as low as 121 23 per share United Therapeutics Corp shares are currently trading down about 7 2 on the day The chart below shows the one year
UTHR,UTHR:UW,BBG000BV5663,SteadyMed Wins Patent Challenge Vs United Therapeutics,2017-04-03 15:55:00 +0000,http://www.investopedia.com/news/steadymed-wins-patent-challenge-stdy-uthr/?partner=YahooSA,SteadyMed Wins Patent Challenge Vs United Therapeutics
UTHR,UTHR:UW,BBG000BV5663,SteadyMed Wins Patent Challenge Vs United Therapeutics,2017-04-03 15:55:00 +0000,http://finance.yahoo.com/r/1c3e0f11-ba81-3156-8646-63db1718716c/steadymed-wins-patent-challenge-stdy-uthr?partner=YahooSA&yptr=yahoo&.tsrc=rss,SteadyMed secured a favorable ruling in a patent dispute against rival United Therapeutics.
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics shares fall after regulatory delays push back product launch,2017-04-03 14:08:48 +0000,http://finance.yahoo.com/news/united-therapeutics-shares-fall-regulatory-140848818.html?.tsrc=rss,United Therapeutics said it would be delaying the launch of an implantable pump until 2018.
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics shares fall after regulatory delays push back product launch,2017-04-03 14:08:48 +0000,http://www.cnbc.com/id/104380563?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104380563,United Therapeutics shares fall after regulatory delays push back product launch
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics loses challenge to its drug patent,2017-04-03 14:07:09 +0000,http://www.bizjournals.com/washington/news/2017/04/03/united-therapeutics-loses-rules-in-challenge.html?ana=yahoo,United Therapeutics loses challenge to its drug patent
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics loses challenge to its drug patent,2017-04-03 14:07:09 +0000,http://finance.yahoo.com/r/d03b5d41-ff5f-34ad-a1af-797c27472f22/united-therapeutics-loses-rules-in-challenge.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Silver Spring-based biotech United Therapeutics Corp. (UTHR) lost a recent challenge to one of its lead patents for its flagship drugs.  The U.S. Patent and Trademark Office's Patent Trial and Appeal Board found that all of the company's claims for the particular patent — which impacts its lead products for treating pulmonary arterial hypertension such as Remodulin, Tyvaso and Orenitram — are not patentable.  In a statement, United Therapeutics officials said they are evaluating all of their options, including possibly appealing the decision in the U.S. Court of Appeals for the Federal Circuit or requesting a rehearing before the patent board."
UTHR,UTHR:UW,BBG000BV5663,Stocks Open Higher; United Therapeutics Dives,2017-04-03 13:42:30 +0000,http://finance.yahoo.com/r/7008fc07-8205-32a1-8eb3-68acd0f79002/stock-futures-set-for-positive-q2-launch-unitedhealth-tesla-rise?src=A00220A&yptr=yahoo&.tsrc=rss,"Stocks opened higher Monday, as small caps gained strength."
UTHR,UTHR:UW,BBG000BV5663,Stocks Open Higher; United Therapeutics Dives,2017-04-03 13:42:30 +0000,http://www.investors.com/market-trend/stock-market-today/stock-futures-set-for-positive-q2-launch-unitedhealth-tesla-rise/?src=A00220A,Stocks Open Higher; United Therapeutics Dives
UTHR,UTHR:UW,BBG000BV5663,"Biotech Movers: Novocure, United Therapeutics, Kite Pharma",2017-04-03 13:29:00 +0000,https://www.thestreet.com/story/14069952/1/biotech-movers-novocure-united-therapeutics-kite-pharma.html?puc=yahoo&cm_ven=YAHOO,"Biotech Movers: Novocure, United Therapeutics, Kite Pharma"
UTHR,UTHR:UW,BBG000BV5663,"Biotech Movers: Novocure, United Therapeutics, Kite Pharma",2017-04-03 13:29:00 +0000,http://finance.yahoo.com/r/49dbaa50-9c55-32ec-9661-4475fd21472d/biotech-movers-novocure-united-therapeutics-kite-pharma.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Novocure, United Therapeutics and Kite Pharma were among the biotech stock movers in early trading Monday."
UTHR,UTHR:UW,BBG000BV5663,Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review,2017-04-03 12:00:00 +0000,http://finance.yahoo.com/news/cardiomes-partner-steadymed-receives-favourable-120000285.html?.tsrc=rss,Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review
UTHR,UTHR:UW,BBG000BV5663,Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review,2017-04-03 12:00:00 +0000,http://finance.yahoo.com/news/cardiomes-partner-steadymed-receives-favourable-120000285.html,[CNW Group] - Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure",2017-04-03 10:56:26 +0000,http://biz.yahoo.com/e/170403/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure"
UTHR,UTHR:UW,BBG000BV5663,6:05 am United Therapeutics announces that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch Implantable System for Remodulin until 2018,2017-04-03 10:05:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#uthr,6:05 am United Therapeutics announces that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch Implantable System for Remodulin until 2018
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump,2017-04-03 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-announces-regulatory-delays-100000541.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 3, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch™ Implantable System for Remodulin® until 2018. United Therapeutics has been working with Medtronic, Inc. to develop Medtronic's proprietary intravascular infusion catheter to be used with Medtronic's implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin, or RemoSynch) for the delivery of Remodulin to treat patients with pulmonary arterial hypertension."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Regulatory Delays For Remosynch Implantable Pump,2017-04-03 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-announces-regulatory-delays-100000541.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 3, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that regulatory delays will result in postponement of the planned U.S. launch of the RemoSynch™ Implantable System for Remodulin® until 2018.  United Therapeutics has been working with Medtronic, Inc. to develop Medtronic's proprietary intravascular infusion catheter to be used with Medtronic's implantable infusion pump and related infusion system components (together referred to as the Implantable System for Remodulin, or RemoSynch) for the delivery of Remodulin to treat patients with pulmonary arterial hypertension."
UTHR,UTHR:UW,BBG000BV5663,"Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise",2017-04-03 00:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jI90mHkdz0/setback-for-acor-in-ampyra-suit-ears-put-on-notice-stdy-on-steady-rise-20170403-00002,"Setback For ACOR In Ampyra Suit, EARS Put On Notice, STDY On Steady Rise"
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure",2017-03-31 17:40:09 +0000,http://biz.yahoo.com/e/170331/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents,2017-03-31 17:15:00 +0000,http://finance.yahoo.com/news/united-therapeutics-announces-decision-patent-171500918.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that the U.S. Patent and Trademark's Office (USPTO) Patent Trial and Appeal Board (PTAB) issued a Final Written Decision in connection with the inter partes review (IPR) of United Therapeutics' U.S. Patent No. 8,497,393 (the '393 patent). The PTAB found that all claims of the '393 patent are not patentable. United Therapeutics is evaluating its options, including the possibility of immediately exercising its right of appeal to the U.S. Court of Appeals for the Federal Circuit or first requesting a rehearing before the PTAB."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Decision From Patent Trial And Appeal Board And Issuance Of New Patents,2017-03-31 17:15:00 +0000,http://finance.yahoo.com/news/united-therapeutics-announces-decision-patent-171500918.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 31, 2017 /PRNewswire/ -- United Therapeutics Corporation (UTHR) today announced that the U.S. Patent and Trademark's Office (USPTO) Patent Trial and Appeal Board (PTAB) issued a Final Written Decision in connection with the inter partes review (IPR) of United Therapeutics' U.S. Patent No. 8,497,393 (the '393 patent).  The PTAB found that all claims of the '393 patent are not patentable.  United Therapeutics is evaluating its options, including the possibility of immediately exercising its right of appeal to the U.S. Court of Appeals for the Federal Circuit or first requesting a rehearing before the PTAB."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Enters Oversold Territory (UTHR),2017-03-31 16:59:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5NJJ3WKIQhM/united-therapeutics-enters-oversold-territory-uthr-cm768371,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
UTHR,UTHR:UW,BBG000BV5663,Four Magic Formula Picks For a Richly Valued Market,2017-03-31 12:58:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Tina5eSnwjQ/four-magic-formula-picks-for-a-richly-valued-market-cm767194,Frothy Pricey Stretched These are among the adjectives used to describe the stock market s valuation these days and they re not even the most ominous When you consider the cardinal rule of investing buy low sell high such descriptors could discourage the most
UTHR,UTHR:UW,BBG000BV5663,Coverage initiated on United Therapeutics by UBS,2017-03-30 13:24:30 +0000,http://finance.yahoo.com/q/ud?s=UTHR,Coverage initiated on United Therapeutics by UBS
UTHR,UTHR:UW,BBG000BV5663,Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?,2017-03-28 08:59:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NUkReh57lvA/why-is-united-therapeutics-uthr-down-56-since-the-last-earnings-report-cm766295,It has been about a month since the last earnings report for United Therapeutics Corporation UTHR Shares have lost about 5 6 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a
UTHR,UTHR:UW,BBG000BV5663,Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?,2017-03-28 06:43:06 +0000,http://finance.yahoo.com/news/why-united-therapeutics-uthr-down-064306412.html,Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?
UTHR,UTHR:UW,BBG000BV5663,Why Is United Therapeutics (UTHR) Down 5.6% Since the Last Earnings Report?,2017-03-28 06:43:06 +0000,http://finance.yahoo.com/news/why-united-therapeutics-uthr-down-064306412.html?.tsrc=rss,United Therapeutics (UTHR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
UTHR,UTHR:UW,BBG000BV5663,Is United Therapeutics a Great Stock for Value Investors?,2017-03-21 16:11:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g9tYMGXIZVU/is-united-therapeutics-a-great-stock-for-value-investors-cm763480,Value investing is easily one of the most popular ways to find great stocks in any market environment After all who wouldn t want to find stocks that are either flying under the radar and are compelling buys or offer up tantalizing discounts when compared to fair value One way to find
UTHR,UTHR:UW,BBG000BV5663,Is United Therapeutics a Great Stock for Value Investors?,2017-03-21 14:05:02 +0000,http://finance.yahoo.com/news/united-therapeutics-great-stock-value-140502765.html,Is United Therapeutics a Great Stock for Value Investors?
UTHR,UTHR:UW,BBG000BV5663,Is United Therapeutics a Great Stock for Value Investors?,2017-03-21 14:05:02 +0000,http://finance.yahoo.com/news/united-therapeutics-great-stock-value-140502765.html?.tsrc=rss,Let's see if United Therapeutics Corporation (UTHR) stock is a good choice for value-oriented investors right now from multiple angles.
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Reaches Analyst Target Price,2017-03-20 15:08:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e33hNptlp_s/united-therapeutics-reaches-analyst-target-price-cm762823,In recent trading shares of United Therapeutics Corp Symbol UTHR have crossed above the average analyst 12 month target price of 140 80 changing hands for 142 08 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
UTHR,UTHR:UW,BBG000BV5663,"How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma",2017-03-20 11:25:00 +0000,http://finance.yahoo.com/news/drug-makers-stocks-faring-orexigen-112500115.html?.tsrc=rss,"Last Friday, shares in La Jolla, California headquartered Orexigen Therapeutics Inc. ended the session 3.76% lower at $4.10.  The stock recorded a trading volume of 182,389 shares.  The Company's shares have surged 141.18% in the previous three months and 135.63% on an YTD basis."
UTHR,UTHR:UW,BBG000BV5663,"How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United Therapeutics, DURECT, and SciClone Pharma",2017-03-20 11:25:00 +0000,http://finance.yahoo.com/news/drug-makers-stocks-faring-orexigen-112500115.html,"[PR Newswire] - Last Friday, shares in La Jolla, California headquartered Orexigen Therapeutics Inc. ended the session 3.76% lower at $4.10. The stock recorded a trading volume of 182,389 shares. The Company's shares have surged 141.18% in the previous three months and 135.63% on an YTD basis."
UTHR,UTHR:UW,BBG000BV5663,3 Drug Stocks With Some of the Highest Profit Margins,2017-03-17 16:07:08 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mKe55hzAWcY/3-drug-stocks-with-some-of-the-highest-profit-margins-cm762233,Investors have an absolute smorgasbord of choices when it comes to the biotech and pharmaceutical industries There are in total well over 300 publicly traded drugmakers to consider investing in Of course many of those drugmakers somewhere near 90 are also losing money The
UTHR,UTHR:UW,BBG000BV5663,3 Drug Stocks With Some of the Highest Profit Margins,2017-03-17 15:03:00 +0000,http://finance.yahoo.com/r/34208e0d-ff90-3cfe-8693-3269431d8eb0/3-drug-stocks-with-some-of-the-highest-profit-marg.aspx?yptr=yahoo&.tsrc=rss,These drugmakers really know how to maximize every dollar they receive in sales!
UTHR,UTHR:UW,BBG000BV5663,3 Drug Stocks With Some of the Highest Profit Margins,2017-03-17 15:03:00 +0000,https://www.fool.com/investing/2017/03/17/3-drug-stocks-with-some-of-the-highest-profit-marg.aspx,3 Drug Stocks With Some of the Highest Profit Margins
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Stock Slumping on Credit Suisse Rating,2017-03-16 18:01:00 +0000,http://finance.yahoo.com/r/9dee4c21-111b-3b96-8d54-4b11ac1ed8f1/united-therapeutics-stock-slumping-on-credit-suisse-rating.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Credit Suisse initiated United Therapeutics with an 'underperform' rating.
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Stock Slumping on Credit Suisse Rating,2017-03-16 18:01:00 +0000,https://www.thestreet.com/story/14047594/1/united-therapeutics-stock-slumping-on-credit-suisse-rating.html?puc=yahoo&cm_ven=YAHOO,United Therapeutics Stock Slumping on Credit Suisse Rating
UTHR,UTHR:UW,BBG000BV5663,Northwell Health and United Therapeutics Announce Strategic Partnership to Advance Bioelectronic Medicine and Cell Therapy,2017-03-09 11:00:00 +0000,http://finance.yahoo.com/news/northwell-health-united-therapeutics-announce-110000786.html?.tsrc=rss,"""Collaboration is the indispensable factor in successful medical research,"" said Kevin J. Tracey, M.D., President and CEO of the Feinstein Institute.  ""With great partners, you can accomplish great things for science and for patients."
UTHR,UTHR:UW,BBG000BV5663,Northwell Health and United Therapeutics Announce Strategic Partnership to Advance Bioelectronic Medicine and Cell Therapy,2017-03-09 11:00:00 +0000,http://finance.yahoo.com/news/northwell-health-united-therapeutics-announce-110000786.html,"[PR Newswire] - ""Collaboration is the indispensable factor in successful medical research,"" said Kevin J. Tracey, M.D., President and CEO of the Feinstein Institute. ""With great partners, you can accomplish great things for science and for patients."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Barclays Global Healthcare Conference,2017-03-07 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-barclays-110000405.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Barclays Global Healthcare Conference,2017-03-07 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-barclays-110000405.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 7, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,Will Alexion’s Research Make Gains in the Inhibitor Space?,2017-02-28 15:36:43 +0000,http://marketrealist.com/2017/02/alexion-pharmaceuticals-continues-advance-research-programs-complement-inhibitor-space/?utm_source=yahoo&utm_medium=feed,Will Alexion’s Research Make Gains in the Inhibitor Space?
UTHR,UTHR:UW,BBG000BV5663,Alnylam Pharmaceuticals Advances Its Patisiran Research Program,2017-02-28 14:09:18 +0000,http://marketrealist.com/2017/02/alnylam-pharmaceuticals-continues-advance-patisiran-research-program-2017/?utm_source=yahoo&utm_medium=feed,Alnylam Pharmaceuticals Advances Its Patisiran Research Program
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Cowen And Company 37th Annual Health Care Conference,2017-02-28 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-cowen-110000711.html?.tsrc=rss,"SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Cowen And Company 37th Annual Health Care Conference,2017-02-28 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-cowen-110000711.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 28, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,UNITED THERAPEUTICS CORP Financials,2017-02-25 18:04:14 +0000,http://finance.yahoo.com/q/is?s=uthr,UNITED THERAPEUTICS CORP Financials
UTHR,UTHR:UW,BBG000BV5663,Vertex Expects Modest Revenue Growth in This,2017-02-24 19:06:02 +0000,http://marketrealist.com/2017/02/vertex-pharmaceuticals-expects-modest-revenue-growth-orkambi-2017/?utm_source=yahoo&utm_medium=feed,Vertex Expects Modest Revenue Growth in This
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics feels squeeze from increased pulmonary hypertension competition,2017-02-23 22:39:20 +0000,http://finance.yahoo.com/r/9579a0ba-624d-37dd-b5a8-0792cf7c81e1/united-therapeutics-feeling-squeeze-from-increased.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"United Therapeutics Corp. (UTHR) blames increasing competition in the pulmonary arterial hypertension space for its lower-than-expected revenue last year, CEO Martine Rothblatt told analysts Wednesday.  During the Silver Spring-based company's fourth-quarter earnings call, Rothblatt said there has been weaker growth for some of its drugs — Orenitram, Tyvaso and Remodulin.  Patients are sticking with alternative therapies, such as a combination of Adcirca with Letairis, longer than expected before switching to its products, she said."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics feels squeeze from increased pulmonary hypertension competition,2017-02-23 22:39:20 +0000,http://www.bizjournals.com/washington/news/2017/02/23/united-therapeutics-feeling-squeeze-from-increased.html?ana=yahoo,United Therapeutics feels squeeze from increased pulmonary hypertension competition
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017",2017-02-23 16:36:29 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-uthr-us-earnings-analysis-2016-by-the-numbers-february-23-2017/,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: 2016 By the Numbers : February 23, 2017"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss,2017-02-23 14:50:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kghKCc6RrnI/united-therapeutics-uthr-down-on-q4-earnings-sales-miss-cm751908,United Therapeutics Corporation UTHR reported adjusted earnings of 2 64 per share including after tax impact of stock based compensation expense for fourth quarter 2016 which missed the Zacks Consensus Estimate of 3 62 by 27 1 Adjusted earnings excluding stock based compensation
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017",2017-02-23 14:18:13 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-uthr-us-earnings-analysis-q4-2016-by-the-numbers-february-23-2017/,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 23, 2017"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss,2017-02-23 14:03:02 +0000,http://finance.yahoo.com/news/united-therapeutics-uthr-down-q4-140302839.html,United Therapeutics (UTHR) Down on Q4 Earnings & Sales Miss
UTHR,UTHR:UW,BBG000BV5663,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation",2017-02-22 22:49:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O3WM1oG6374/better-buy-organovo-holdings-inc-vs-united-therapeutics-corporation-cm751645,Pitting Organovo Holdings NASDAQ ONVO against United Therapeutics NASDAQ UTHR might seem a bit strange Organovo is much smaller than United Therapeutics Their products have little in common However both of these healthcare stocks have increased by similar levels
UTHR,UTHR:UW,BBG000BV5663,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation",2017-02-22 22:08:43 +0000,http://www.fool.com/investing/2017/02/22/better-buy-organovo-holdings-inc-vs-united-therape.aspx,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today,2017-02-22 14:00:00 +0000,http://biz.yahoo.com/cc/6/155846.html,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today
UTHR,UTHR:UW,BBG000BV5663,"Earnings Reaction History: United Therapeutics Corporation, 44.4% Follow-Through Indicator, 3.5% Sensitive",2017-02-22 11:46:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6DtDwNBBY88/earnings-reaction-history-united-therapeutics-corporation-444-follow-through-indicator-35-sensitive-cm751045,Expected Earnings Release 02 22 2017 PremarketExpected Earnings Release 02 22 2017 Premarket Avg Extended Hours Dollar Volume 905 210Avg Extended Hours Dollar Volume 905 210 United Therapeutics Corporation UTHR is due to issue its quarterly earnings report in the
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats 4Q profit forecasts,2017-02-22 11:43:25 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-beats-4q-profit-114325257.html,United Therapeutics beats 4Q profit forecasts
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition",2017-02-22 11:09:13 +0000,http://biz.yahoo.com/e/170222/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition"
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 10-K, Annual Report",2017-02-22 11:08:53 +0000,http://biz.yahoo.com/e/170222/uthr10-k.html,"UNITED THERAPEUTICS CORP Files SEC form 10-K, Annual Report"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports 2016 Fourth Quarter And Annual Financial Results,2017-02-22 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-reports-2016-110000458.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended ..."
UTHR,UTHR:UW,BBG000BV5663,"Pre-Market Earnings Report for February 22, 2017 :  TJX, SO, HCN, DISH, HST, NCLH, GRMN, ARCC, NI, UTHR, LAMR, SIX",2017-02-21 21:16:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/e64H_HcVPtM/pre-market-earnings-report-for-february-22-2017-tjx-so-hcn-dish-hst-nclh-grmn-arcc-ni-uthr-lamr-six-cm750906,The following companies are expected to report earnings prior to market open on 02 22 2017 Visit our Earnings Calendar for a full list of expected earnings releases TJX Companies Inc TJX is reporting for the quarter ending January 31 2017 The
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Report Fourth Quarter And Annual 2016 Financial Results Before The Market Opens On Wednesday, February 22, 2017",2017-02-15 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-report-fourth-110000957.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 15, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its fourth quarter and annual 2016 ..."
UTHR,UTHR:UW,BBG000BV5663,Your Guide To 2017's Emerging Pharmaceuticals Catalysts,2017-02-07 19:39:19 +0000,http://finance.yahoo.com/news/guide-2017s-emerging-pharmaceuticals-catalysts-193919266.html,Your Guide To 2017's Emerging Pharmaceuticals Catalysts
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year",2017-02-03 11:27:17 +0000,http://biz.yahoo.com/e/170203/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year"
UTHR,UTHR:UW,BBG000BV5663,"Notable ETF Inflow Detected - XBI, CLVS, ACAD, UTHR",2017-02-02 17:32:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pakwiJavqtM/notable-etf-inflow-detected-xbi-clvs-acad-uthr-cm742278,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the XBI SPDR S amp P Biotech ETF US Equities Symbol XBI where we have detected an approximate 136 6 million dollar inflow that s a 5 3 increase week over week
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi",2017-01-30 11:06:53 +0000,http://biz.yahoo.com/e/170130/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financi"
UTHR,UTHR:UW,BBG000BV5663,D.C.-area biotech stocks fall on Trump's tough talk on industry,2017-01-12 04:10:08 +0000,http://www.bizjournals.com/washington/news/2017/01/11/d-c-area-biotech-stocks-fall-on-trumps-tough-talk.html?ana=yahoo,D.C.-area biotech stocks fall on Trump's tough talk on industry
UTHR,UTHR:UW,BBG000BV5663,VIVUS Licenses Rights to PAH Drugs from Selten Pharma,2017-01-11 22:57:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FmZshYzSroU/vivus-licenses-rights-to-pah-drugs-from-selten-pharma-cm732456,VIVUS Inc VVUS acquired exclusive global rights to develop and commercialize pulmonary arterial hypertension PAH drugs tacrolimus and ascomycin from private biotech company Selten Pharma Inc VIVUS share price has gained 24 in the past one year while the Zacks
UTHR,UTHR:UW,BBG000BV5663,VIVUS Licenses Rights to PAH Drugs from Selten Pharma,2017-01-11 20:24:08 +0000,http://finance.yahoo.com/news/vivus-licenses-rights-pah-drugs-202408223.html,VIVUS Licenses Rights to PAH Drugs from Selten Pharma
UTHR,UTHR:UW,BBG000BV5663,New Strong Buy Stocks for January 5th,2017-01-05 15:41:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/la00zEA1JB4/new-strong-buy-stocks-for-january-5th-cm729853,Here are 5 stocks added to the Zacks Rank 1 Strong Buy List today United Therapeutics Corporation UTHR This biotechnology company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0 7 over the last 30 days UTD THERAPEUTIC Price and
UTHR,UTHR:UW,BBG000BV5663,New Strong Buy Stocks for January 5th,2017-01-05 13:27:01 +0000,http://finance.yahoo.com/news/strong-buy-stocks-january-5th-132701544.html,New Strong Buy Stocks for January 5th
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At 35th Annual J.P. Morgan Healthcare Conference,2017-01-05 11:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-35th-110000400.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 5, 2017 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016,2016-12-29 18:14:25 +0000,http://marketrealist.com/2016/12/vertex-pharmaceuticals-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Vertex Pharmaceuticals Expects Strong Revenue Growth in 2016
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics' PAH Suite Bodes Well, Competition Rife",2016-12-29 16:57:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hG8xhZ5cme4/united-therapeutics-pah-suite-bodes-well-competition-rife-cm727421,On Dec 29 2016 we issued an updated report on United Therapeutics Corporation UTHR United Therapeutics posted better than expected earnings in the third quarter of 2016 even though revenues missed estimates Nevertheless its top line also improved on a year over year driven by
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics' PAH Suite Bodes Well, Competition Rife",2016-12-29 15:10:03 +0000,http://finance.yahoo.com/news/united-therapeutics-pah-suite-bodes-151003329.html,"United Therapeutics' PAH Suite Bodes Well, Competition Rife"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics: Will RemoSynch Become a Key Growth Driver?,2016-12-29 14:06:33 +0000,http://marketrealist.com/2016/12/remosynch-expected-become-key-growth-driver-united-therapeutics-future-years/?utm_source=yahoo&utm_medium=feed,United Therapeutics: Will RemoSynch Become a Key Growth Driver?
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics’ Robust Research Pipeline,2016-12-29 12:36:09 +0000,http://marketrealist.com/2016/12/robust-research-pipeline-expected-boost-united-therapeutics-revenues-future-years/?utm_source=yahoo&utm_medium=feed,United Therapeutics’ Robust Research Pipeline
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics: Will Orenitram See Strong Patient Demand?,2016-12-28 19:05:28 +0000,http://marketrealist.com/2016/12/orenitram-may-witness-strong-patient-demand-future-years/?utm_source=yahoo&utm_medium=feed,United Therapeutics: Will Orenitram See Strong Patient Demand?
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics: Why Tyvaso Is Still a Key Growth Driver,2016-12-28 17:35:40 +0000,http://marketrealist.com/2016/12/tyvaso-continues-key-growth-driver-united-therapeutics-future-years/?utm_source=yahoo&utm_medium=feed,United Therapeutics: Why Tyvaso Is Still a Key Growth Driver
UTHR,UTHR:UW,BBG000BV5663,Why United Therapeutics Expects Strong Revenue Growth,2016-12-28 15:55:16 +0000,http://marketrealist.com/2016/12/united-therapeutics-expects-strong-revenue-growth-2016/?utm_source=yahoo&utm_medium=feed,Why United Therapeutics Expects Strong Revenue Growth
UTHR,UTHR:UW,BBG000BV5663,Dupixent Is Being Explored for Multiple Indications in 2016,2016-12-16 15:35:56 +0000,http://marketrealist.com/2016/12/dupixent-explored-multiple-indications-2016/?utm_source=yahoo&utm_medium=feed,Dupixent Is Being Explored for Multiple Indications in 2016
UTHR,UTHR:UW,BBG000BV5663,The 3 Most Profit-Friendly Biotech Stocks,2016-12-12 22:56:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dn-hgcu2isQ/the-3-most-profit-friendly-biotech-stocks-cm720399,Developing game changing medicine isn t easy and it s certainly not cheap It can cost hundreds of millions of dollars to create new drugs and with a clinical trial failure rate of 90 the risks to biotech companies are enormous Yet the reward can be even bigger when drugmakers get
UTHR,UTHR:UW,BBG000BV5663,The 3 Most Profit-Friendly Biotech Stocks,2016-12-12 21:21:06 +0000,http://www.fool.com/investing/2016/12/12/the-3-most-profit-friendly-biotech-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 3 Most Profit-Friendly Biotech Stocks
UTHR,UTHR:UW,BBG000BV5663,Are there buying opportunities in health care?,2016-12-07 22:07:00 +0000,http://finance.yahoo.com/video/buying-opportunities-health-care-220700643.html,Are there buying opportunities in health care?
UTHR,UTHR:UW,BBG000BV5663,NBIX Continues to Study Valbenazine for Tourette Syndrome,2016-12-02 13:05:07 +0000,http://marketrealist.com/2016/12/neurocrine-biosciences-continues-explore-valbenazine-tourette-syndrome-indication/?utm_source=yahoo&utm_medium=feed,NBIX Continues to Study Valbenazine for Tourette Syndrome
UTHR,UTHR:UW,BBG000BV5663,"Hedge Funds Are Selling Patterson Companies, Inc. (PDCO)",2016-12-02 09:29:21 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-selling-patterson-companies-inc-pdco-496234/,"Hedge Funds Are Selling Patterson Companies, Inc. (PDCO)"
UTHR,UTHR:UW,BBG000BV5663,Pig organs to save lives by end of decade: United Therape...,2016-12-01 19:25:00 +0000,http://finance.yahoo.com/video/pig-organs-save-lives-end-192500332.html,Pig organs to save lives by end of decade: United Therape...
UTHR,UTHR:UW,BBG000BV5663,"Hedge Funds Are Buying WellCare Health Plans, Inc. (WCG)",2016-12-01 16:32:52 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-buying-wellcare-health-plans-inc-wcg-2-492255/,"Hedge Funds Are Buying WellCare Health Plans, Inc. (WCG)"
UTHR,UTHR:UW,BBG000BV5663,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?,2016-11-30 16:17:42 +0000,http://www.fool.com/investing/2016/11/29/what-happens-when-your-biotech-stock-faces-generic.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?
UTHR,UTHR:UW,BBG000BV5663,What Happens When Your Biotech Stock Faces Generic Competition Lawsuits?,2016-11-29 17:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8E40uMN9Euw/what-happens-when-your-biotech-stock-faces-generic-competition-lawsuits-cm715218,Image source Getty Images Few things are as inevitable and frustrating as generic competition in the pharma industry After overcoming the high risks of failure in drug development and pouring money into sales and marketing the owner of a successful drug can see its revenue
UTHR,UTHR:UW,BBG000BV5663,J&J (JNJ) Reportedly Approaches Actelion for Acquisition,2016-11-25 16:06:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ebZq9P20IOs/jj-jnj-reportedly-approaches-actelion-for-acquisition-cm713976,Reportedly Johnson amp Johnson JNJ recently approached Swiss biotechnology company Actelion Ltd ALIOF with a potential takeover offer Bloomberg reported that according to sources the companies are holding initial talks after J amp J s offer Actelion is a leader in the pulmonary
UTHR,UTHR:UW,BBG000BV5663,J&J (JNJ) Reportedly Approaches Actelion for Acquisition,2016-11-25 13:32:01 +0000,http://finance.yahoo.com/news/j-j-jnj-reportedly-approaches-133201845.html,J&J (JNJ) Reportedly Approaches Actelion for Acquisition
UTHR,UTHR:UW,BBG000BV5663,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-21 18:19:33 +0000,http://www.fool.com/investing/2016/11/20/5-most-expensive-medicare-drugs-and-which-companie.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them
UTHR,UTHR:UW,BBG000BV5663,5 Most Expensive Medicare Drugs -- and Which Companies Are Getting Rich From Them,2016-11-20 21:49:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/hDywVZ9ryNo/5-most-expensive-medicare-drugs-and-which-companies-are-getting-rich-from-them-cm711719,Medicare spends billions of dollars each year on prescription drugs That s not surprising What might be surprising though is how much the federal healthcare program spends per patient on some of these drugs Here are the five most expensive drugs covered by Medicare on a per
UTHR,UTHR:UW,BBG000BV5663,4 Biotech Stocks to Buy After Clinton’s Defeat,2016-11-14 18:29:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wcolSbFSImw/4-biotech-stocks-to-buy-after-clintons-defeat-cm708827,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips The 2016 election certainly was a historic one just not in the way people expected Rather than Hillary Clinton becoming the first female U S president Donald Trump managed to pull off the biggest upset
UTHR,UTHR:UW,BBG000BV5663,How Greater Washington stocks fared post-election,2016-11-09 21:29:45 +0000,http://www.bizjournals.com/washington/news/2016/11/09/how-greater-washington-stocks-are-faring-post.html?ana=yahoo,How Greater Washington stocks fared post-election
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : November 9, 2016",2016-11-09 12:27:28 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-uthr-us-november-9-2016/,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : November 9, 2016"
UTHR,UTHR:UW,BBG000BV5663,"Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns",2016-11-08 22:35:56 +0000,http://www.insidermonkey.com/blog/palo-alto-investorss-bets-on-abiomed-inc-abmd-united-therapeutics-corporation-uthr-and-other-stocks-lift-its-q3-returns-485345/,"Palo Alto Investors’s Bets on ABIOMED, Inc. (ABMD), United Therapeutics Corporation (UTHR) and Other Stocks Lift Its Q3 Returns"
UTHR,UTHR:UW,BBG000BV5663,"FXH, WCG, SGEN, UTHR: Large Outflows Detected at ETF",2016-11-08 19:40:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DiyeO0PYCKU/fxh-wcg-sgen-uthr-large-outflows-detected-at-etf-cm705695,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Health Care AlphaDEX Fund Symbol FXH where we have detected an approximate 51 0 million dollar outflow that s a 5 2 decrease week over week
UTHR,UTHR:UW,BBG000BV5663,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns,2016-11-04 05:17:09 +0000,http://www.insidermonkey.com/blog/mallinckrodt-plc-mnk-depomed-inc-depo-helped-consonance-capital-to-massive-q3-returns-484890/,Mallinckrodt PLC (MNK) & Depomed Inc (DEPO) Helped Consonance Capital to Massive Q3 Returns
UTHR,UTHR:UW,BBG000BV5663,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors,2016-11-01 21:54:00 +0000,http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-215400099.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / November 1, 2016 / Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary ..."
UTHR,UTHR:UW,BBG000BV5663,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Fiduciary Duty by the Board of United Therapeutics Corporation -- UTHR",2016-10-31 21:50:00 +0000,http://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-215000216.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / October 31, 2016 / Levi & Korsinsky announces it has commenced an investigation of United Therapeutics Corporation (NASDAQ: UTHR) concerning possible breaches of fiduciary duty ..."
UTHR,UTHR:UW,BBG000BV5663,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating United Therapeutics Corporation for Potential Breaches Of Fiduciary Duty By Its Board of Directors,2016-10-31 17:06:00 +0000,http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-170600065.html,"[PR Newswire] - NEW YORK, Oct. 31, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim ..."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016",2016-10-31 14:39:19 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-uthr-us-earnings-analysis-q3-2016-by-the-numbers-october-31-2016/,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q3, 2016 By the Numbers : October 31, 2016"
UTHR,UTHR:UW,BBG000BV5663,We Did The Math LRGF Can Go To $27,2016-10-31 14:15:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2awq9NE6glY/we-did-the-math-lrgf-can-go-to-27-cm700943,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss",2016-10-28 15:35:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jF0NKpmW6hc/united-therapeutics-uthr-beats-q3-earnings-sales-miss-cm700153,United Therapeutics Corporation UTHR reported adjusted earnings of 3 63 per share including after tax impact of stock based compensation expense for third quarter 2016 which beat the Zacks Consensus Estimate of 3 47 by 4 61 Revenues for the reported quarter increased 5 6 year over year
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss",2016-10-28 13:58:01 +0000,http://finance.yahoo.com/news/united-therapeutics-uthr-beats-q3-135801925.html,"United Therapeutics (UTHR) Beats Q3 Earnings, Sales Miss"
UTHR,UTHR:UW,BBG000BV5663,Edited Transcript of UTHR earnings conference call or presentation 27-Oct-16 1:00pm GMT,2016-10-27 19:46:52 +0000,http://finance.yahoo.com/news/edited-transcript-uthr-earnings-conference-194652988.html,Edited Transcript of UTHR earnings conference call or presentation 27-Oct-16 1:00pm GMT
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics upping the ante on R&D spending,2016-10-27 18:55:11 +0000,http://www.bizjournals.com/washington/news/2016/10/27/united-therapeutics-upping-the-ante-on-r-dspending.html?ana=yahoo,United Therapeutics upping the ante on R&D spending
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today,2016-10-27 13:00:00 +0000,http://biz.yahoo.com/cc/1/154571.html,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today
UTHR,UTHR:UW,BBG000BV5663,Q3 2016 United Therapeutics Corp Earnings Release - Before Market Open,2016-10-27 11:07:05 +0000,http://biz.yahoo.com/research/earncal/20161027.html?t=uthr,Q3 2016 United Therapeutics Corp Earnings Release - Before Market Open
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats 3Q profit forecasts,2016-10-27 10:20:52 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-beats-3q-profit-102052213.html,United Therapeutics beats 3Q profit forecasts
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition",2016-10-27 10:07:39 +0000,http://biz.yahoo.com/e/161027/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition"
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report",2016-10-27 10:07:38 +0000,http://biz.yahoo.com/e/161027/uthr10-q.html,"UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports Third Quarter 2016 Financial Results,2016-10-27 10:06:06 +0000,http://www.publicnow.com/view/59813209282F3D918FB5F77E35922B61E3AB1F52,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports Third Quarter 2016 Financial Results,2016-10-27 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-reports-third-100000344.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September 30, ..."
UTHR,UTHR:UW,BBG000BV5663,6 Undervalued Stocks Trading Below the Peter Lynch Value,2016-10-26 23:25:10 +0000,http://finance.yahoo.com/news/6-undervalued-stocks-trading-below-232510710.html,6 Undervalued Stocks Trading Below the Peter Lynch Value
UTHR,UTHR:UW,BBG000BV5663,"ETF’s with exposure to United Therapeutics Corp. : October 26, 2016",2016-10-26 16:41:13 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-united-therapeutics-corp-october-26-2016/,"ETF’s with exposure to United Therapeutics Corp. : October 26, 2016"
UTHR,UTHR:UW,BBG000BV5663,Is a Surprise Coming for United Therapeutics (UTHR) This Earnings Season?,2016-10-21 15:03:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I0XUmS3WJ70/is-a-surprise-coming-for-united-therapeutics-uthr-this-earnings-season-cm696444,Investors are always looking for stocks that are poised to beat at earnings season and United Therapeutics Corporation UTHR may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because United Therapeutics is
UTHR,UTHR:UW,BBG000BV5663,Is a Surprise Coming for United Therapeutics (UTHR) This Earnings Season?,2016-10-21 13:13:01 +0000,http://finance.yahoo.com/news/surprise-coming-united-therapeutics-uthr-131301489.html,Is a Surprise Coming for United Therapeutics (UTHR) This Earnings Season?
UTHR,UTHR:UW,BBG000BV5663,Celgene (CELG) Q3 Earnings: What's in Store for the Stock?,2016-10-20 15:29:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aSbcsZF3ltU/celgene-celg-q3-earnings-whats-in-store-for-the-stock-cm695954,Celgene Corporation CELG is scheduled to report third quarter 2016 results on Oct 27 before the opening bell Celgene s track record has been decent with the company beating earnings estimates on three occasions over the trailing four quarters Overall the company has delivered an
UTHR,UTHR:UW,BBG000BV5663,What's in Store for BioMarin (BMRN) This Earnings Season?,2016-10-20 15:28:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/holgreg2CpE/whats-in-store-for-biomarin-bmrn-this-earnings-season-cm695926,BioMarin Pharmaceutical Inc BMRN is scheduled to report third quarter 2016 results on Oct 27 after the market closes In the last reported quarter the company had posted a positive surprise of 78 00 Let s see how things are shaping up for this announcement Factors Influencing
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Report Third Quarter 2016 Financial Results Before The Market Opens On Thursday, October 27, 2016",2016-10-20 10:08:03 +0000,http://www.publicnow.com/view/53302B0A0540FC22C001932033FE59C7F6C01F73,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2016 financial results ..."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Report Third Quarter 2016 Financial Results Before The Market Opens On Thursday, October 27, 2016",2016-10-20 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-report-third-100000998.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will report its third quarter 2016 financial results ..."
UTHR,UTHR:UW,BBG000BV5663,"Noteworthy ETF Outflows: FXH, SGEN, UTHR, LPNT",2016-10-19 16:48:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/85ZV91YsMKQ/noteworthy-etf-outflows-fxh-sgen-uthr-lpnt-cm695415,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Health Care AlphaDEX Fund Symbol FXH where we have detected an approximate 23 6 million dollar outflow that s a 2 2 decrease week over week
UTHR,UTHR:UW,BBG000BV5663,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation",2016-10-14 20:42:30 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TmBQPG95MFU/better-buy-organovo-holdings-inc-vs-united-therapeutics-corporation-cm693655,Human liver tissue Image source Getty Images At first glance Organovo Holdings Inc NASDAQ ONVO and United Therapeutics Corporation NASDAQ UTHR might seem to have little in common Heck at second glance the two companies might not seem to have much in common It
UTHR,UTHR:UW,BBG000BV5663,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation",2016-10-14 19:31:49 +0000,http://www.fool.com/investing/2016/10/14/better-buy-organovo-holdings-inc-vs-united-therape.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Better Buy: Organovo Holdings, Inc. vs. United Therapeutics Corporation"
UTHR,UTHR:UW,BBG000BV5663,Will These 5 Drug Stocks Be Big Winners This Earnings Season?,2016-10-13 15:43:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1Nl68JgbnNs/will-these-5-drug-stocks-be-big-winners-this-earnings-season-cm692807,The third quarter earnings season has kicked off with Alcoa reporting results earlier this week With the Q3 earnings season expected to pick pace in the coming days the market will be focused on seeing if the overall earnings picture will improve this season Q2 was the 5th quarter in a
UTHR,UTHR:UW,BBG000BV5663,Will These 5 Drug Stocks Be Big Winners This Earnings Season?,2016-10-13 13:46:01 +0000,http://finance.yahoo.com/news/5-drug-stocks-big-winners-134601176.html,Will These 5 Drug Stocks Be Big Winners This Earnings Season?
UTHR,UTHR:UW,BBG000BV5663,10 LGBT CEOs Who Weren't Afraid To Come Out,2016-10-11 17:50:06 +0000,http://finance.yahoo.com/news/10-lgbt-ceos-werent-afraid-175006763.html,10 LGBT CEOs Who Weren't Afraid To Come Out
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : October 10, 2016",2016-10-10 12:11:27 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bullish-manner-uthr-us-october-10-2016/,"United Therapeutics Corp. breached its 50 day moving average in a Bullish Manner : UTHR-US : October 10, 2016"
UTHR,UTHR:UW,BBG000BV5663,6 Healthcare Stocks Investors Can't Miss in Q3 Earnings,2016-10-07 18:43:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DZWZlJnc5pI/6-healthcare-stocks-investors-cant-miss-in-q3-earnings-cm690471,Controversies surrounding drug prices are again making it to the headlines this time spurred by the EpiPen price hike issue Generic drug maker Mylan N V drew flak from lawmakers for over pricing its epinephrine auto injector EpiPen severe allergic reactions around the end of Aug
UTHR,UTHR:UW,BBG000BV5663,6 Healthcare Stocks Investors Can't Miss in Q3 Earnings,2016-10-07 16:22:04 +0000,http://finance.yahoo.com/news/6-healthcare-stocks-investors-cant-162204234.html,6 Healthcare Stocks Investors Can't Miss in Q3 Earnings
UTHR,UTHR:UW,BBG000BV5663,"Top 5 Pharma stocks with strong earnings momentum. : October 5, 2016",2016-10-05 14:04:43 +0000,http://www.capitalcube.com/blog/index.php/top-5-pharma-stocks-with-strong-earnings-momentum-october-5-2016/,"Top 5 Pharma stocks with strong earnings momentum. : October 5, 2016"
UTHR,UTHR:UW,BBG000BV5663,How The Pieces Add Up: RFG Targets $136,2016-09-30 14:22:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NtZZn1f_sPE/how-the-pieces-add-up-rfg-targets-136-cm687064,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : September 29, 2016",2016-09-29 14:19:25 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-value-analysis-nasdaquthr-september-29-2016/,"United Therapeutics Corp. – Value Analysis (NASDAQ:UTHR) : September 29, 2016"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Chilled On M&A Fever Amid Actelion, Bayer Rivalry",2016-09-28 20:31:29 +0000,http://www.investors.com/news/technology/biotech-united-chilled-on-ma-fever-amid-actelion-bayer-rivalry/,"United Therapeutics Chilled On M&A Fever Amid Actelion, Bayer Rivalry"
UTHR,UTHR:UW,BBG000BV5663,5 Stocks with Exciting Price-to-Book Ratios,2016-09-28 12:21:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ez1K6UUc7vg/5-stocks-with-exciting-price-to-book-ratios-cm685749,When you re an investor the last thing you want is to pay too much for a stock or miss a bargain price This is where value investing comes into play In value investing investors pick stocks that are cheap but fundamentally strong Among the various ratios to identify value stocks
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : September 28, 2016",2016-09-28 12:17:07 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-breached-its-50-day-moving-average-in-a-bearish-manner-uthr-us-september-28-2016/,"United Therapeutics Corp. breached its 50 day moving average in a Bearish Manner : UTHR-US : September 28, 2016"
UTHR,UTHR:UW,BBG000BV5663,5 Stocks with Exciting Price-to-Book Ratios,2016-09-28 10:44:10 +0000,http://finance.yahoo.com/news/5-stocks-exciting-price-book-104410998.html,5 Stocks with Exciting Price-to-Book Ratios
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K/A, Regulation FD Disclosure",2016-09-27 15:24:54 +0000,http://biz.yahoo.com/e/160927/uthr8-k_a.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K/A, Regulation FD Disclosure"
UTHR,UTHR:UW,BBG000BV5663,"Top 5 Pharma stocks by value : September 27, 2016",2016-09-27 14:29:04 +0000,http://www.capitalcube.com/blog/index.php/top-5-pharma-stocks-by-value-september-27-2016/,"Top 5 Pharma stocks by value : September 27, 2016"
UTHR,UTHR:UW,BBG000BV5663,3 Great Stocks You Can Buy on Sale,2016-09-27 13:21:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AOMmJXvxy6U/3-great-stocks-you-can-buy-on-sale-cm684982,Image Source Getty Images Mr Market can be moody near sighted and irrational But he isn t always correct There are times when stocks are unfairly punished While that can make investors emotional it can also signal an opportunity to buy great companies on sale Here s why
UTHR,UTHR:UW,BBG000BV5663,3 Great Stocks You Can Buy on Sale,2016-09-27 12:11:00 +0000,http://www.fool.com/investing/2016/09/27/3-great-stocks-you-can-buy-on-sale.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Great Stocks You Can Buy on Sale
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure",2016-09-27 12:02:04 +0000,http://biz.yahoo.com/e/160927/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Regulation FD Disclosure"
UTHR,UTHR:UW,BBG000BV5663,Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential,2016-09-22 14:35:23 +0000,http://247wallst.com/healthcare-business/2016/09/22/analyst-has-3-biotech-stocks-to-buy-with-over-100-upside-potential/,Analyst Has 3 Biotech Stocks to Buy With Over 100% Upside Potential
UTHR,UTHR:UW,BBG000BV5663,First Week of UTHR May 2017 Options Trading,2016-09-20 16:21:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u8VO2DYnrQ8/first-week-of-uthr-may-2017-options-trading-cm682003,Investors in United Therapeutics Corp Symbol UTHR saw new options become available this week for the May 2017 expiration One of the key inputs that goes into the price an option buyer is willing to pay is the time value so with 241 days until expiration the newly available
UTHR,UTHR:UW,BBG000BV5663,"Noteworthy ETF Outflows: FXH, VEEV, EW, UTHR",2016-09-13 17:47:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0lVF212sj4c/noteworthy-etf-outflows-fxh-veev-ew-uthr-cm678922,Looking today at week over week shares outstanding changes among the universe of ETFs covered at ETF Channel one standout is the First Trust Health Care AlphaDEX Fund Symbol FXH where we have detected an approximate 24 3 million dollar outflow that s a 2 1 decrease week over week
UTHR,UTHR:UW,BBG000BV5663,How Analysts See United Therapeutics’ Continued Performance,2016-09-01 12:04:29 +0000,http://marketrealist.com/2016/08/analyst-recommendations-united-therapeutics-2016/?utm_source=yahoo&utm_medium=feed,How Analysts See United Therapeutics’ Continued Performance
UTHR,UTHR:UW,BBG000BV5663,"ETF’s with exposure to United Therapeutics Corp. : August 31, 2016",2016-08-31 15:58:13 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-united-therapeutics-corp-august-31-2016/,"ETF’s with exposure to United Therapeutics Corp. : August 31, 2016"
UTHR,UTHR:UW,BBG000BV5663,Physician and Payer Relationships to Increase UTHR’s Drug Access,2016-08-31 15:04:55 +0000,http://marketrealist.com/2016/08/strong-physician-payer-relationships-expected-increase-access-united-therapeutics-drugs/?utm_source=yahoo&utm_medium=feed,Physician and Payer Relationships to Increase UTHR’s Drug Access
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Makes Novel Technologies a Priority,2016-08-31 14:05:03 +0000,http://marketrealist.com/2016/08/united-therapeutics-explores-novel-technologies-strengthening-drug-pipeline-2016/?utm_source=yahoo&utm_medium=feed,United Therapeutics Makes Novel Technologies a Priority
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics’ Research Efforts Key to Boosting Stock,2016-08-31 12:05:16 +0000,http://marketrealist.com/2016/08/united-therapeutics-research-pipeline-focused-classic-corridor-indifference/?utm_source=yahoo&utm_medium=feed,United Therapeutics’ Research Efforts Key to Boosting Stock
UTHR,UTHR:UW,BBG000BV5663,$1 Billion Sales Target in Place for Tyvaso,2016-08-30 22:04:06 +0000,http://marketrealist.com/2016/08/united-therapeutics-expects-tyvaso-annual-sales-reach-1-billion/?utm_source=yahoo&utm_medium=feed,$1 Billion Sales Target in Place for Tyvaso
UTHR,UTHR:UW,BBG000BV5663,Generic Competition Not a Threat to UTHR’s Remodulin,2016-08-30 20:04:21 +0000,http://marketrealist.com/2016/08/united-therapeutics-expects-safeguard-remodulin-sales-generic-competition-2016/?utm_source=yahoo&utm_medium=feed,Generic Competition Not a Threat to UTHR’s Remodulin
UTHR,UTHR:UW,BBG000BV5663,Strong Growth Projected for UTHR’s Hypertension Drugs,2016-08-30 18:30:54 +0000,http://marketrealist.com/2016/08/united-therapeutics-pulmonary-arterial-hypertension-drugs-may-witness-strong-growth-2016/?utm_source=yahoo&utm_medium=feed,Strong Growth Projected for UTHR’s Hypertension Drugs
UTHR,UTHR:UW,BBG000BV5663,Why UTHR Trades at Lower Multiples Compared to Its Peers,2016-08-30 18:30:47 +0000,http://marketrealist.com/2016/08/united-therapeutics-trading-lower-valuation-multiples-compared-peers-2016/?utm_source=yahoo&utm_medium=feed,Why UTHR Trades at Lower Multiples Compared to Its Peers
UTHR,UTHR:UW,BBG000BV5663,UTHR Makes Notable Cross Below Critical Moving Average,2016-08-24 22:45:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0p2hxaXHLrQ/uthr-makes-notable-cross-below-critical-moving-average-cm669761,"In trading on Wednesday, shares of United Therapeutics Corp (Symbol UTHR) crossed below their 200 day moving average of $125.86, changing hands as low as $124.22 per share. United Therapeutics Corp shares are currently trading off about 3.7% on"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Hurt By Competitive Pressure,2016-08-22 16:13:45 +0000,http://finance.yahoo.com/news/united-therapeutics-hurt-competitive-pressure-161345421.html,United Therapeutics Hurt By Competitive Pressure
UTHR,UTHR:UW,BBG000BV5663,This Company Could Grow Organs in the Lab -- and It's Not Organovo Holdings,2016-08-20 17:44:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0yq8dpiJZoI/this-company-could-grow-organs-in-the-lab-and-its-not-organovo-holdings-cm668131,"Image source  Getty Images.  A few years back, Organovo Holdings (NASDAQ  ONVO) was seen as the solution to organ transplant waiting lists. The argument went that Organovo, which creates 3D liver tissue samples"
UTHR,UTHR:UW,BBG000BV5663,This Company Could Grow Organs in the Lab -- and It's Not Organovo Holdings,2016-08-20 16:05:00 +0000,http://www.fool.com/investing/2016/08/20/this-company-could-grow-organs-in-the-lab-and-its.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,This Company Could Grow Organs in the Lab -- and It's Not Organovo Holdings
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At The 2016 Wedbush PacGrow Healthcare Conference,2016-08-10 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-present-2016-100000357.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 10, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,"ETF’s with exposure to United Therapeutics Corp. : August 5, 2016",2016-08-05 18:03:05 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-united-therapeutics-corp-august-5-2016/,"ETF’s with exposure to United Therapeutics Corp. : August 5, 2016"
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016",2016-08-04 14:14:07 +0000,http://www.capitalcube.com/blog/index.php/united-therapeutics-corp-uthr-us-earnings-analysis-q2-2016-by-the-numbers-august-4-2016/,"United Therapeutics Corp. :UTHR-US: Earnings Analysis: Q2, 2016 By the Numbers : August 4, 2016"
UTHR,UTHR:UW,BBG000BV5663,"Worst Performance YTD: MasterCard, Lazard",2016-08-04 03:51:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dCBcYhBP760/worst-performance-ytd-mastercard-lazard-cm660129,"Thanks to the GuruFocus All In One screener, we selected the worst performing stocks of the year that have solid performances over the past 10 years and guarantee profitability and a solid financial situation. BP Prudhoe Bay Royalty Trust"
UTHR,UTHR:UW,BBG000BV5663,5 Mid-Cap Stocks With Low Enterprise Multiples,2016-08-04 02:52:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6G3Ikt4Qw2U/5-mid-cap-stocks-with-low-enterprise-multiples-cm660086,"This article appeared first onThe Stock Market Blueprint Blog. In this edition of Watchlist Wednesday, we highlight five mid cap stocks with low enterprise multiples, as displayed on the Enterprise Multiple screen . The enterprise multiple is a price"
UTHR,UTHR:UW,BBG000BV5663,These Five Stocks Show a Combination of Value and Growth,2016-08-03 22:44:15 +0000,http://finance.yahoo.com/news/five-stocks-show-combination-value-224415265.html,These Five Stocks Show a Combination of Value and Growth
UTHR,UTHR:UW,BBG000BV5663,"Worst Performance YTD: MasterCard, Lazard",2016-08-03 22:03:08 +0000,http://finance.yahoo.com/news/worst-performance-ytd-mastercard-lazard-220308573.html,"Worst Performance YTD: MasterCard, Lazard"
UTHR,UTHR:UW,BBG000BV5663,5 Mid-Cap Stocks With Low Enterprise Multiples,2016-08-03 19:29:53 +0000,http://finance.yahoo.com/news/5-mid-cap-stocks-low-192953853.html,5 Mid-Cap Stocks With Low Enterprise Multiples
UTHR,UTHR:UW,BBG000BV5663,Inside Amgen’s Analyst Recommendations for 2016,2016-08-03 15:04:27 +0000,http://marketrealist.com/2016/07/inside-amgens-analyst-recommendations-2016/?utm_source=yahoo&utm_medium=feed,Inside Amgen’s Analyst Recommendations for 2016
UTHR,UTHR:UW,BBG000BV5663,4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts,2016-08-03 13:55:25 +0000,http://247wallst.com/healthcare-business/2016/08/03/4-biotech-stocks-with-up-to-300-upside-potential-and-upcoming-catalysts/,4 Biotech Stocks With Up to 300% Upside Potential and Upcoming Catalysts
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today,2016-07-28 13:00:00 +0000,http://biz.yahoo.com/cc/1/153251.html,United Therapeutics Corp Earnings Call scheduled for 9:00 am ET today
UTHR,UTHR:UW,BBG000BV5663,Q2 2016 United Therapeutics Corp Earnings Release - Before Market Open,2016-07-28 11:07:06 +0000,http://biz.yahoo.com/research/earncal/20160728.html?t=uthr,Q2 2016 United Therapeutics Corp Earnings Release - Before Market Open
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics tops Street 2Q forecasts,2016-07-28 10:34:35 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-tops-street-2q-103435366.html,United Therapeutics tops Street 2Q forecasts
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports Second Quarter 2016 Financial Results,2016-07-28 10:28:13 +0000,http://www.publicnow.com/view/B35CDC8A42E6F8DD0A12CCF5FC1420F5ADCFCAE4,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the second quarter ended June ..."
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report",2016-07-28 10:09:31 +0000,http://biz.yahoo.com/e/160728/uthr10-q.html,"UNITED THERAPEUTICS CORP Files SEC form 10-Q, Quarterly Report"
UTHR,UTHR:UW,BBG000BV5663,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition",2016-07-28 10:09:31 +0000,http://biz.yahoo.com/e/160728/uthr8-k.html,"UNITED THERAPEUTICS CORP Files SEC form 8-K, Results of Operations and Financial Condition"
UTHR,UTHR:UW,BBG000BV5663,Nivalis (NVLS): Can the Stock Surprise This Earnings Season?,2016-07-28 00:23:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NPnTyXf_utU/nivalis-nvls-can-the-stock-surprise-this-earnings-season-cm656083,"Nivalis Therapeutics, Inc.NVLS is expected to report second quarter 2016 results on Aug 1. Last quarter, the company had posted a negative surprise of 15.91%. Let's see how things are shaping up for this announcement. Factors at Play Nivalis,"
UTHR,UTHR:UW,BBG000BV5663,Alexion (ALXN) Q2 Earnings: Stock Likely to Disappoint,2016-07-26 19:28:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UiQyW0IQ8Q8/alexion-alxn-q2-earnings-stock-likely-to-disappoint-cm654801,"Alexion Pharmaceuticals, Inc.ALXN is scheduled to report second quarter 2016 results on Jul 28, before the opening bell. The company's track record has been far from encouraging. Over the last four reported quarters, the company posted an average negative"
UTHR,UTHR:UW,BBG000BV5663,Bristol-Myers (BMY): Stock to Beat Earnings Again in Q2,2016-07-25 18:09:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_jfXORMMGpQ/bristol-myers-bmy-stock-to-beat-earnings-again-in-q2-cm654275,"Bristol Myers Squibb CompanyBMY is scheduled to report second quarter 2016 results on Jul 28, before the opening bell. Last quarter, the company reported a positive earnings surprise of 12.12%. Bristol Myers has been seen to consistently beat earnings"
UTHR,UTHR:UW,BBG000BV5663,Celgene (CELG) Q2 Earnings: Can the Stock Pull a Surprise?,2016-07-25 17:13:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bNgsRyxhxOA/celgene-celg-q2-earnings-can-the-stock-pull-a-surprise-cm654178,"Celgene CorporationCELG is scheduled to report second quarter 2016 results on Jul 28, before the market opens. Last quarter, the company reported a positive earnings surprise of 12.38%. Celgene's track record has been mixed with the company beating earnings"
UTHR,UTHR:UW,BBG000BV5663,What Do Analysts Recommend for United Therapeutics?,2016-07-22 17:12:23 +0000,http://marketrealist.com/2016/07/united-therapeutics-key-analyst-recommendations-2016/?utm_source=yahoo&utm_medium=feed,What Do Analysts Recommend for United Therapeutics?
UTHR,UTHR:UW,BBG000BV5663,Will Orenitram Lose Market Share to Uptravi in 2016?,2016-07-22 17:12:21 +0000,http://marketrealist.com/2016/07/orenitram-may-lose-market-share-uptravi-2016/?utm_source=yahoo&utm_medium=feed,Will Orenitram Lose Market Share to Uptravi in 2016?
UTHR,UTHR:UW,BBG000BV5663,Tyvaso Sales Expected to Fall Marginally in 2Q16,2016-07-22 17:12:18 +0000,http://marketrealist.com/2016/07/tyvaso-sales-expected-marginally-decline-2q16/?utm_source=yahoo&utm_medium=feed,Tyvaso Sales Expected to Fall Marginally in 2Q16
UTHR,UTHR:UW,BBG000BV5663,Why United Therapeutics (UTHR) Might Surprise This Earnings Season,2016-07-22 15:17:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/h3S0iqllhgg/why-united-therapeutics-uthr-might-surprise-this-earnings-season-cm653289,"Investors are always looking for stocks that are poised to beat at earnings season and United Therapeutics CorporationUTHR may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for"
UTHR,UTHR:UW,BBG000BV5663,Why United Therapeutics (UTHR) Might Surprise This Earnings Season,2016-07-22 12:50:12 +0000,http://finance.yahoo.com/news/why-united-therapeutics-uthr-might-125012925.html,Why United Therapeutics (UTHR) Might Surprise This Earnings Season
UTHR,UTHR:UW,BBG000BV5663,Martine Rothblatt: Organ manufacturing could make us the next Google,2016-07-22 12:18:47 +0000,http://www.bizjournals.com/washington/blog/techflash/2016/07/martine-rothblatt-on-human-organ-manufacturing.html?ana=yahoo,Martine Rothblatt: Organ manufacturing could make us the next Google
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Announce Second Quarter 2016 Financial Results Before The Market Opens On Thursday, July 28, 2016",2016-07-21 10:00:00 +0000,http://finance.yahoo.com/news/united-therapeutics-corporation-announce-second-100000401.html,"[PR Newswire] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 21, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its second quarter 2016 financial ..."
UTHR,UTHR:UW,BBG000BV5663,How Will Remodulin Sales Fare in 2Q16?,2016-07-20 20:13:20 +0000,http://marketrealist.com/2016/07/remodulin-sales-expected-witness-modest-growth-2q16/?utm_source=yahoo&utm_medium=feed,How Will Remodulin Sales Fare in 2Q16?
UTHR,UTHR:UW,BBG000BV5663,3 Biotech Stocks That Could Soar Over the Next 12 Months,2016-07-19 21:57:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2MEUflzz4XA/3-biotech-stocks-that-could-soar-over-the-next-12-months-cm651449,"Image source  Flickr.  Biotech has been so bloodied and battered this year that the sector is 30% off its peak from last summer, as measured by the iShares Nasdaq Biotech ETF ."
UTHR,UTHR:UW,BBG000BV5663,3 Biotech Stocks for Conservative Investors,2016-07-17 21:09:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H8nEd3BB7YI/3-biotech-stocks-for-conservative-investors-cm650280,"Image source  Getty Images.  The biotechnology industry is chock full of risky stocks, but that doesn't mean conservative investors should ignore it entirely. You might be surprised to find that more than a"
UTHR,UTHR:UW,BBG000BV5663,Merrimack Stock Up on Fast Track Status for Seribantumab,2016-07-08 00:36:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AaT3F9NmAf4/merrimack-stock-up-on-fast-track-status-for-seribantumab-cm646129,"Merrimack Pharmaceuticals, Inc. 's shares MACK were up 4.4% after the company announced that the FDA has granted Fast Track designation to seribantumab (MM 121) for the treatment of heregulin positive, locally advanced or metastatic non small cell lung"
UTHR,UTHR:UW,BBG000BV5663,Merck KGaA/Pfizer Avelumab in JAVELIN Ovarian 100 Study,2016-07-07 22:38:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rHm81NNKg98/merck-kgaapfizer-avelumab-in-javelin-ovarian-100-study-cm646061,"Merck KGaAMKGAF and its partner Pfizer Inc. PFE announced that they have initiated a phase III study JAVELIN Ovarian 100 on avelumab, in combination with platinum based chemotherapy, for the treatment of patients with locally advanced or metastatic disease"
UTHR,UTHR:UW,BBG000BV5663,Valeant (VRX) Loses European Rights to Psoriasis Candidate,2016-07-06 17:37:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b7h0xsQLhfY/valeant-vrx-loses-european-rights-to-psoriasis-candidate-cm645363,"Valeant Pharmaceuticals International, Inc.VRX announced that its partner AstraZeneca AZN has amended the company's license to its pipeline candidate, brodalumab. As per the amendment, AstraZeneca has decided to terminate Valeant's rights to develop and commercialize brodalumab in Europe. We"
UTHR,UTHR:UW,BBG000BV5663,Merck to Acquire Brazilian Animal Health Company for $400M,2016-07-05 17:50:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ofGk4Kg8wg4/merck-to-acquire-brazilian-animal-health-company-for-400m-cm644821,"Merck & Co. Inc.MRK announced that it will acquire the controlling interest in Vallée S.A., a Brazil based privately held producer of animal health products. Under the terms, Merck's animal health business will acquire 93% of Vallée's shares for"
UTHR,UTHR:UW,BBG000BV5663,Add Up The Parts: FTHI Could Be Worth $22,2016-05-12 13:23:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z73ygxGBZKU/add-up-the-parts-fthi-could-be-worth-22-cm620005,"Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12 month forward target price, and computed the weighted average"
UTHR,UTHR:UW,BBG000BV5663,3 Dirt-Cheap Biotech Stocks To Buy,2016-05-04 13:49:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SPzEzna3nmM/3-dirt-cheap-biotech-stocks-to-buy-cm615931,"SOURCE  FLICKR USER ELLIOTT BROWN  Sometimes stocks sell down to prices that look too good to be true, but just because a company appears cheap doesn't mean that its a good"
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Announces Executive Leadership Changes,2016-04-28 10:18:23 +0000,http://www.publicnow.com/view/052CC63CF84924F3476D7071CB55A17F2651B688,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D. has stepped down as the company's ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports First Quarter 2016 Financial Results,2016-04-28 10:18:22 +0000,http://www.publicnow.com/view/A45480E760384326AA5E4FD81A8F477867C86314,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 28, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the first quarter ended March ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats 1Q profit forecasts,2016-04-28 10:17:36 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-beats-1q-profit-101736499.html,United Therapeutics beats 1Q profit forecasts
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At Deutsche Bank 41st Annual Health Care Conference,2016-04-27 10:18:58 +0000,http://www.publicnow.com/view/26F86A52DC08355CF4526ACF0C5214C036017278,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 27, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Martine Rothblatt, Ph.D., Chairman and Co-Chief Executive ..."
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Announce First Quarter 2016 Financial Results Before Market Open On Thursday, April 28, 2016",2016-04-20 10:20:18 +0000,http://www.publicnow.com/view/C48DD44FC91B0126B09258470E174E053FD5A523,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2016 financial ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats Street 4Q forecasts,2016-02-25 11:39:35 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-beats-street-4q-113935016.html,United Therapeutics beats Street 4Q forecasts
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference,2016-01-06 11:30:35 +0000,http://www.noodls.com/view/FE26BC3A1F50D25FE069BA845E54445E49F35743,"[at noodls] - and , /PRNewswire/ -- (: UTHR) announced today that , Ph.D., President and Co-Chief Executive Officer, of will provide an overview and update on the company's business at the 34 Annual in . ... This is ..."
UTHR,UTHR:UW,BBG000BV5663,Clinigen Group and United Therapeutics Initiate Managed Access Program for UNITUXIN™ (Dinutuximab) Injection for High Risk Neuroblastoma,2015-11-04 07:17:13 +0000,http://www.noodls.com/view/A1039994B3A5C0A4713F2FD546DEACB0AF522931,"[at noodls] - The program, which will be managed by Idis MA, will enable individual adolescents and children as young as 12 months old with high risk neuroblastoma to receive UNITUXIN™ (dinutuximab) injection in specific ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Reports Third Quarter 2015 Financial Results,2015-10-27 10:25:17 +0000,http://www.noodls.com/view/A4CF69F5E6B3625454D538BDAFDD20639B1AA41E,[at noodls] - United Therapeutics Corporation Reports Third Quarter 2015 Financial Results
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics tops Street 3Q forecasts,2015-10-27 10:15:51 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-tops-street-3q-101551073.html,United Therapeutics tops Street 3Q forecasts
UTHR,UTHR:UW,BBG000BV5663,"United Therapeutics Corporation To Announce Third Quarter 2015 Financial Results Before Market Open On Tuesday, October 27, 2015",2015-10-21 10:15:13 +0000,http://www.noodls.com/view/E3EAA380E316D3085D7F1BE3A9447CC56A843C0B,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2015 financial results ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Additional $500 Million Share Repurchase Program,2015-10-15 10:32:02 +0000,http://www.noodls.com/view/F614E30885977791BD593CC1490158D3653F67F6,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Announces Settlement of Patent Litigation with Sandoz Inc.,2015-09-30 10:28:06 +0000,http://www.noodls.com/view/2311BA03E90A455337631DB867DBB4427B7EAD6D,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million,2015-08-19 10:16:46 +0000,http://www.noodls.com/view/A582827033F49B8CD00169B182737E811EF081C0,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare ..."
UTHR,UTHR:UW,BBG000BV5663,European Commission Grants Marketing Authorisation for Unituxin™ (dinutuximab) for the Treatment of Paediatric High-Risk Neuroblastoma,2015-08-17 10:13:05 +0000,http://www.noodls.com/view/BC7EF5C167226FC0ECCE8875BC0CEFF64C214315,"[at noodls] - SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing ..."
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics beats 2Q profit forecasts,2015-07-28 10:16:20 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-beats-2q-profit-101620648.html,United Therapeutics beats 2Q profit forecasts
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics reports 1Q loss,2015-04-28 10:13:04 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-reports-1q-loss-101304468.html,United Therapeutics reports 1Q loss
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics reports 3Q loss,2014-10-28 10:27:39 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-reports-3q-loss-102739765--finance.html,United Therapeutics reports 3Q loss
UTHR,UTHR:UW,BBG000BV5663,United Therapeutics rises on drug-patent ruling,2014-08-29 18:02:16 +0000,http://sg.finance.yahoo.com/news/united-therapeutics-rises-drug-patent-180216959--finance.html,United Therapeutics rises on drug-patent ruling
